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ABSTRACT 
The Medicaid expansion, one of the key provisions under the Affordable Care Act (ACA), has 
turned Medicaid into a larger player in the US healthcare system. The intent of the expansion was 
to increase access to essential healthcare services such as post-acute care (PAC) for low-income 
individuals. Studies have shown that variation in Medicare spending is attributed to the variation 
in post-acute care (PAC) utilization which includes care in home health, skilled nursing facilities 
(SNF), inpatient rehabilitation facilities (IRF), and long-term acute care hospitals (LTACH). 
However, very little is known about PAC utilization in the Medicaid population. For instance, 
Pennsylvania expanded Medicaid in January 2015, initially under a 1115 waiver and then under 
the original terms of the ACA. Many more individuals and families of low socioeconomic status 
were able to enroll in the Medicaid program as a result of the expansion. With studies pointing to 
PAC utilization and spending as the driver of variation in Medicare healthcare costs, the same may 
pertain to the Medicaid population. 
 Chapter 1 provides the purpose, findings, and implications of the dissertation.  
 Chapter 2 is a retrospective cohort study that determines the association between insurance 
type, either enrolled in Medicaid or commercial insurance, and the likelihood of being admitted to 
an inpatient PAC facility. The study found that hospitalized Medicaid beneficiaries were as likely 
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as similar patients with commercial insurance to be admitted to any PAC facility but less likely to 
be admitted to an inpatient PAC facility (SNF, IRF, LTACH). This would inform policymakers 
that new Medicaid enrollees, which tend to be low-income and nondisabled adults, will certainly 
increase the cost of the Medicaid program. 
 Chapter 3 is a retrospective cohort study that determines whether Medicaid managed care 
utilizes inpatient PAC differently than its FFS counterpart. The study found that Medicaid 
managed care beneficiaries were more likely to be admitted to an inpatient PAC than their FFS 
counterparts. This has significant cost implications since the majority of all Medicaid beneficiaries 
in the United States were enrolled in an MCO. 
 Chapter 4 is a retrospective cohort study that determines the degree to which patient 
outcomes observed among Medicaid beneficiaries was mediated by variation in the intensity of 
PAC utilization. The study found that PAC utilization patterns for hospitalized Medicaid 
beneficiaries impacted readmissions and mortality to a degree. While we could not determine 
whether more PAC utilization would result in better quality of care, the effect of these patterns on 
outcomes should encourage states to standardize their approach to PAC and take necessary steps 
to improve patient management and care coordination among providers. 
Public Health Significance 
  This dissertation addressed the three tenets of the healthcare iron triangle: access, cost, and 
quality. It will inform policymakers on how new Medicaid enrollees due to the expansion can 
potentially affect future cost to the program and impact the outcomes of Medicaid beneficiaries. 
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1.0  INTRODUCTION 
The Medicaid expansion, one of the key provisions under the Affordable Care Act (ACA), has 
turned Medicaid into a larger player in the US healthcare system. The intent of the expansion was 
to increase access to essential healthcare services such as post-acute care (PAC) for low-income 
individuals. Studies have shown that variation in Medicare spending is attributed to the variation 
in post-acute care (PAC) utilization which includes care in home health, skilled nursing facilities 
(SNF), inpatient rehabilitation facilities (IRF), and long-term acute care hospitals (LTACH). 
However, very little is known about PAC utilization in the Medicaid population. For instance, 
Pennsylvania expanded Medicaid in January 2015, initially under a 1115 waiver and then under 
the original terms of the ACA. Many more individuals and families of low socioeconomic status 
were able to enroll in the Medicaid program as a result of the expansion. With studies pointing to 
PAC utilization and spending as the driver of variation in Medicare healthcare costs, the same may 
pertain to the Medicaid population.  
The purpose of this dissertation was to determine how Medicaid coverage affected 
placement in PAC and how those patterns impacted patient outcomes. Determining PAC 
utilization in Medicaid would provide insight on the potential increased cost and demand of health 
services due to the expansion. In the first study, we found that hospitalized Medicaid beneficiaries 
were as likely as similar patients with commercial insurance to be admitted to any PAC facility 
but less likely to be admitted to an inpatient PAC facility (SNF, IRF, LTACH). This would inform 
policymakers that new Medicaid enrollees, which tend to be low-income and nondisabled adults, 
will certainly increase the cost of the Medicaid program. For the second paper, we discovered that 
Medicaid managed care beneficiaries were more likely to be admitted to an inpatient PAC than 
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their FFS counterparts. This has significant cost implications since the majority of all Medicaid 
beneficiaries in the United States were enrolled in an MCO. Lastly, the third paper revealed that 
PAC utilization patterns for hospitalized Medicaid beneficiaries impacted readmissions and 
mortality to a degree. While we could not determine whether more PAC utilization would result 
in better quality of care, the effect of these patterns on outcomes should encourage states to 
standardize their approach to PAC and take necessary steps to improve patient management and 
care coordination among providers. Ultimately, these three analyses will inform policymakers on 
how new Medicaid enrollees due to the expansion can potentially affect future cost to the program 
and impact the outcomes of Medicaid beneficiaries.  
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2.0  THE EFFECT OF MEDICAID INSURANCE COVERAGE ON DISCHARGE TO 
AN INPATIENT POST-ACUTE CARE FACILITY 
2.1 ABSTRACT 
Introduction 
Post-acute care (PAC) utilization is a major driver of health care spending in the United States. At 
the same time, the recent Medicaid expansion carried out under the Affordable Care Act (ACA) 
will extend health insurance to the previously uninsured, individuals that historically have low 
rates of PAC use. This policy created a tension by which newly insured individuals may contribute 
to the growth in health care spending through PAC utilization. In this context, it is important to 
understand how Medicaid insurance influences current PAC use as a preface to understanding the 
impact of insurance expansion on PAC.  
 
Objective 
To determine the association between insurance type, either enrolled in Medicaid or commercial 
insurance, and the likelihood of being admitted to an inpatient PAC facility. 
 
Methods 
We performed a retrospective cohort study using the Pennsylvania Healthcare Cost Containment 
Council inpatient discharge dataset from 2008 to 2010 Q1. Eligible patients were between the ages 
of 18 – 64, insured through either Medicaid or commercial insurance, and diagnosed in the top 20 
diagnosis related group that were discharged to an inpatient PAC facility. Multivariate logistic 
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regression models were used to estimate the association between insurance type and discharge to 
an inpatient PAC facility. 
 
Results 
A total of 133,996 records were in the final analytic cohort, of whom 14,397 (10.7%) were 
discharged to an inpatient PAC facility. Conditional on discharge to PAC, commercially insured 
patients were more likely to be discharged to a high intensive inpatient PAC facility such as an 
inpatient rehabilitation facility (IRF) or long-term acute care hospital (LTACH) (60.1% vs. 38.1%; 
p < 0.001). These relationships were not reflected in the multivariate analysis. Medicaid patients 
were considerably more likely to be admitted to a high intensive inpatient PAC facility (IRF, 
LTACH) than individuals with commercial insurance (OR: 1.60; 95% CI: 1.51 – 1.70; p < 0.001). 
Subsequently, Medicaid patients were less likely to be admitted to an inpatient PAC facility (SNF, 
IRF, LTACH) than commercially insured individuals (OR: 0.87; 95% CI: 0.84 – 0.91; p < 0.001). 
 
Conclusions 
Hospitalized Medicaid beneficiaries were as likely as similar patients with commercial insurance 
to be admitted to a PAC facility but less likely to be admitted to an inpatient PAC facility. 
Nevertheless, the data suggests that Medicaid expansion may lead to an increase in overall PAC 
use due to the demand of services from new Medicaid enrollees. At the same time, Medicaid 
beneficiaries tend to be admitted to more intensive forms of PAC due to increased access in urban 
areas. To the degree that appropriate PAC can produce health and financial benefits, the data 
highlights opportunities for states to standardize their approach to PAC, thereby offsetting 
increases in PAC spending associated with Medicaid expansion. 
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2.2 INTRODUCTION 
Healthcare reformers in the past and present have endured the difficulty of balancing access, cost 
and quality; the tenets of the healthcare iron triangle. Over the past fifty years, these tenets have 
been continuously deliberated within Medicaid, the public health insurance program primarily for 
low-income families and individuals. The Medicaid expansion, recently carried out under the 
Affordable Care Act (ACA), has turned Medicaid into a larger player in the US healthcare system. 
As a result of the Expansion, Medicaid enrollment in April 2015 has increased by 21% to over 71 
million Americans since the enactment of the ACA in 2010 (Kaiser Family Foundation, 2015c). 
This number is projected to further increase significantly if the 19 states that have thus far not 
expanded choose to do so, and the uninsured or individuals in the coverage gap (i.e. above the 
income requirement for Medicaid but below the lower limit to qualify for subsidies for the 
insurance marketplace) are enrolled through the insurance marketplace as required by the 
individual mandate. 
As a result of the ACA, the uninsurance rate has dropped considerably from a peak of 
18.2% in 2010 to 10.7% in the first quarter of 2015 (Kaiser Family Foundation, 2015a). While it 
is remarkable to see a large portion of uninsured individuals obtain health insurance in a short 
period of time, it is expected that such increases would lead to a significant rise in healthcare 
utilization and expenditures. This is because the new enrollees as a result of the Medicaid 
expansion are likely to be low-income and nondisabled adults which is different than current 
Medicaid enrollees who tend to be disabled adults, adults with children, or extremely poor 
especially in states with very low income requirements. In addition, for states that decided to 
expand Medicaid well after the implementation of the ACA, individuals previously in the coverage 
gap now qualify for Medicaid. These individuals are expected to utilize health services more so 
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than when they were previously uninsured. One bellwether example of this may be post-acute care, 
which we define here as non-acute inpatient health care services that occur immediately following 
an acute care hospitalization. For instance, among stroke survivors, uninsured patients were 
approximately half as likely to be discharged to an inpatient post-acute care (PAC) facility than 
privately insured patients (L. Skolarus, Meurer, Burke, Bettger, & Lisabeth, 2012).  
PAC utilization, which includes care in home health, skilled nursing facilities (SNF), 
inpatient rehabilitation facilities (IRF), and long-term acute care hospitals (LTACH) could mean 
the difference in terms of quality of life for patients that need to rehabilitate towards living a normal 
life. These PAC settings vary in costs and intensity of care. The least costly and intensive setting 
is home health which provides skilled nursing and other therapy at the patient’s home. Home health 
does not require a preceding hospital stay and home health care services are provided whenever it 
is deemed medically necessary for the patient. SNFs provide skilled nursing care and therapy that 
cannot be done at the home due to more complex medical conditions and surgeries. Consequently, 
SNFs are more costly than home health care. IRFs provide care to medically complex patients who 
require intensive rehabilitation from a multidisciplinary team of healthcare providers. Care at an 
IRF is significantly more expensive than care at a SNF. Finally, the most expensive PAC setting 
is an LTACH since they treat patients with chronic critical illness who require care for an extended 
period of time. Generally, LTACH patients are transferred from the intensive care unit of a hospital 
which means individuals are often mechanically ventilated or severely debilitated due to their 
complex medical condition.  
According to a report by the Medicare Payment Advisory Commission (MedPAC), PAC 
is a major driver of both overall healthcare spending and variation across regions (Medicare 
Payment Advisory Commission, 2011). While it is unknown whether this trend is similar in 
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Medicaid or commercial insurance, it is expected that stakeholders will focus on cost control by 
improving PAC utilization. With the Medicaid expansion, previously uninsured individuals are 
now more likely to utilize services such as PAC. This creates an opportunity to expand PAC in 
ways that may lead to better outcomes such as improved health status, fewer readmissions, and 
shorter hospital length of stay. On the other hand, the expansion of PAC use may significantly 
increase cost while not necessarily lead to better outcomes. 
Currently, there is little literature on how the Medicaid expansion impacts PAC use. 
However, we do know that Medicaid tends to have lower reimbursement rates than Medicare and 
private insurance, which could affect utilization of PAC. In 2012, Medicaid programs paid on 
average 66% of the amount Medicare reimburses for the same services and only six states have 
comparable or higher reimbursement rates for Medicaid than Medicare (Zuckerman, 2012). These 
lower rates may limit access to PAC, especially the more intensive and expensive settings. 
Incidentally, a few studies have suggested that regions with higher Medicaid fee rates are 
associated with higher physician acceptance rates for new Medicaid patients (Decker, 2007, 2012). 
Nevertheless, other studies have shown that higher Medicaid fees alone do not necessarily increase 
access and quality of care significantly (Cunningham & O’Malley, 2009; Shen & Zuckerman, 
2005). The ACA mandated increases in Medicaid fees to Medicare levels to encourage provider 
participation for the expansion; however, the rate increase expired at the end of 2014 with only 15 
states continuing to participate (Kaiser Family Foundation, 2012; Smith, Gifford, & Ellis, 2014). 
In the end, it is unclear what role Medicaid has in the current PAC marketplace.  
In anticipation of increased cost in Medicaid, states are looking to implement cost control 
measures such as transitioning to or expanding managed care, tightening drug formularies, and 
implementing stricter utilization management controls on PAC. As a result, there is concern 
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whether Medicaid patients would be able to receive the appropriate level of rehabilitation intensity 
after an inpatient visit. Inappropriate discharge could lead to poorer outcomes such as higher 
mortality and hospital readmissions (Mor, Intrator, Feng, & Grabowski, 2010). Since hospitals 
have taken cuts in reimbursement because of the ACA (Gruber, 2010), providers have looked for 
ways to improve margins such as insuring the uninsured through Medicaid and making sure these 
patients are appropriately discharged to the correct setting in a timely matter. One study that looked 
at PAC for joint replacements reported that Medicaid patients were significantly less likely to 
receive more intensive PAC than individuals with commercial insurance or Medicare with similar 
severity of illness (Freburger et al., 2011). Ultimately, hospitals are looking to avoid hospital 
readmissions and incur extra costs. However, it is not known whether these patients would 
substantially benefit from a more intensive PAC setting. PAC options such as SNFs and IRFs do 
improve health outcomes in certain conditions (Buntin, Colla, Deb, Sood, & Escarce, 2010; 
Kramer et al., 1997), but likely at a cost that Medicaid would not cover for their lower-risk patients. 
While the Medicaid expansion has improved the healthcare safety net for the country, many 
individuals have the perception that Medicaid insurance meant receiving lower quality of care than 
private insurance. In addition, the stigma associated with public insurance programs and poverty 
permeates throughout the low-income population (H. Allen, Wright, Harding, & Broffman, 2014). 
As a result, we sought to determine whether having Medicaid as opposed to commercial insurance 
had an effect on the course of treatment through a patient’s episode of care (Figure 1). In theory, 
sicker patients such as individuals with high number of comorbidities are likely to be discharged 
to high intensive PAC settings which have the ability to provide the required rehabilitation and 
care necessary for recovery. However, we believe that insurance type has an important impact on 
discharge to an inpatient PAC facility. A significant discrepancy in PAC utilization between 
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Medicaid and commercial insurance would open up the discussion on whether Medicaid provides 
sufficient and good quality of care especially for the sickest of patients. On the other hand, 
administering care more efficiently and effectively could explain the differences in PAC utilization 
between insurance types.  
This study has important implications. This study would inform policymakers on what is 
expected for PAC utilization when a state decides to expand Medicaid. Specifically, we focused 
on the utilization of new Medicaid enrollees as a results of the expansion which tend to be 
nondisabled adults. In this paper, we are determining whether there is an association between 
insurance type, either enrolled in Medicaid or commercial insurance, and the likelihood of being 
admitted to an inpatient PAC facility such as a SNF, IRF, or LTACH. Given previous literature, 
we hypothesize that individuals with commercial insurance are likely to go to an inpatient PAC 
facility than Medicaid recipients. In this study, we used an administrative dataset provided by the 
state of Pennsylvania to compare individuals that were either covered by commercial insurance or 
Medicaid. 
2.3 STUDY DATA AND METHODS 
2.3.1 Study Design and Population 
This was a retrospective cohort study using hospital discharge data from the Pennsylvania Health 
Care Cost Containment Council (PHC4) inpatient administrative dataset. This dataset contains 
detailed demographic and utilization variables for all inpatient discharges statewide (Pennsylvania 
Health Care Cost Containment Council). The study population consists of Pennsylvania patients 
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aged 18 – 64 who were either enrolled in Medicaid (fee-for-service or managed care) or 
commercial insurance from January 1, 2008 to March 31, 2010. The reason for this age limitation 
was to exclude individuals who were dually-eligible for Medicare and Medicaid, since Medicare 
cost-sharing rules would bias the results. In addition, the cohort was limited to the top 20 diagnosis 
related groups (DRG) that were discharged to an inpatient PAC facility. Patients in the top 20 
DRGs represented about 36% of all patients discharged to an inpatient PAC facility. While we lost 
a significant number of patients, limiting the analysis to the top 20 DRGs created a more 
homogeneous cohort for robust comparison. 
2.3.2 Study Variables 
We acquired patient demographics from the discharge records in the PHC4 dataset, and we created 
comorbidity indicators using an algorithm developed by Elixhauser which relies on ICD-9-CM 
diagnoses and procedure codes (Agency for Health Care Research and Quality; Elixhauser, 
Steiner, Harris, & Coffey, 1998). Intensive care unit (ICU) admission and length of stay were 
determined using revenue codes (revenue code 200 – 202, 207 – 213, 219) provided by the PHC4 
revenue code dataset (Quan, Parsons, & Ghali, 2004). Mechanical ventilation was identified using 
ICD-9-CM procedure codes (Quan et al., 2004). We believe admission to the ICU and mechanical 
ventilation are good indicators of patient severity of illness. The PHC4 dataset also contains the 
MediQual Atlas Severity of Illness System which is derived from clinical variables collected at 
the facility and generated to obtain a predicted probability of death (Pennsylvania Health Care 
Cost Containment Council, 2010).   
The primary outcome variable was whether the hospitalization ended with a discharge to 
an inpatient PAC facility. This includes a SNF, IRF, or LTACH. Medicaid generally does not pay 
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for care at an LTACH, but allows it under strict exceptions. We kept patients who were discharged 
to an LTACH in the analysis because excluding this group would introduce selection bias and 
leaves out a significant portion of patients who need PAC. PAC utilization was identified using 
the discharge codes in the PHC4 inpatient records. The primary exposure was whether the patient 
was covered by commercial insurance or Medicaid, and this was identified using the primary payer 
code in the PHC4 discharge records. We decided to compare only commercial insurance to 
Medicaid because these insurers must maintain healthy profit margins while allowing great 
flexibility to patients in terms of the provider choice and type of care. To stay viable, both 
commercial insurance and Medicaid require cost optimization, which gives us a more balanced 
comparison of inpatient PAC utilization. 
2.3.3 Analysis 
We examined patient and clinical characteristics of the Medicaid and commercial groups using 
summary statistics. Differences between the comparison groups were tested using t-tests and chi-
square tests for continuous and categorical variables, respectively. To determine the relationship 
between discharge to an inpatient PAC facility and insurance status, we used a multivariate logistic 
regression model. The model was risk-adjusted for all demographic variables, mechanical 
ventilation, ICU admission, hospital and ICU length of stay, Elixhauser comorbidities, and PHC4 
region. We adjusted for geographic region since rural areas of Pennsylvania had more limited 
access to inpatient PAC facilities than urban areas. To account for differences in provider 
characteristics and clustering, we also performed a hierarchical linear model with random hospital 
effects. While we included geographic region as a fixed effect, the random effects model considers 
the hospital-to-hospital variability of patient treatment depending on access to an inpatient PAC 
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facility. The MediQual predicted probability of death was not used as a predictor due to a high 
proportion of missing values (18.8%) in the discharge records. All continuous variables such as 
age were converted to quadratic splines to provide a better model fit (Howe et al., 2011).  Data 
management and statistical analyses were performed using SAS 9.4 (SAS Institute Inc.) and Stata 
SE 14.0 (StataCorp. 2015. Stata Statistical Software: Release 14. College Station).  A p-value of 
0.05 or below was classified as significant. 
2.4 STUDY RESULTS 
Over the study period (2008 – 2010 Q1), there were 3,575,127 inpatient records in Pennsylvania. 
After applying the exclusion criteria, 133,996 records were in the final analytic cohort (Figure 2). 
Patients with commercial insurance were discharged to a PAC facility more often than Medicaid 
patients (29.8% vs. 22.4%); however, this difference is primarily due to the differences in home 
health (Table 2). Overall, 14,373 or 10.7% of patients with Medicaid or commercial insurance 
were discharged to an inpatient PAC facility. The patient characteristics of the two study samples 
stratified by insurance status are shown in Table 3. Medicaid recipients that were discharged to an 
inpatient PAC were younger and had a significantly higher proportion of nonwhites (42.6% vs. 
20.4%; p < 0.001) than individuals insured commercially. In addition, the majority of Medicaid 
patients were admitted through the emergency department and were more likely to be presented 
with multiple and more severe comorbidities. During the hospital stay, Medicaid patients were 
more likely to be admitted to the ICU and mechanically ventilated with a significantly higher 
predicted probability of death and longer hospital and ICU length of stay than commercially 
insured patients. However, a greater proportion of commercially insured patients were discharged 
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to higher intensive PAC facilities (IRF, LTACH) than their Medicaid counterparts (60.1% vs. 
38.1%; p < 0.001). 
The multivariate logistic regression analysis examined three outcomes of varying 
intensities (Table 4). The analysis suggested that Medicaid patients were more likely to be admitted 
to an inpatient PAC facility (SNF, IRF, LTACH) than commercially insured individuals (OR: 1.08; 
95% CI: 1.04 – 1.13; p < 0.001; AUC = 0.807). In contrast, for high intensive PAC which only 
includes more expensive IRFs and LTACHs, Medicaid patients were considerably less likely to 
be admitted to a higher intensive inpatient PAC facility (IRF, LTACH) than individuals with 
commercial insurance (OR: 0.57; 95% CI: 0.54 – 0.60; p < 0.001; AUC = 0.767). Interestingly, if 
all PAC settings were incorporated in the analysis which includes the less intensive and less costly 
home health care, then Medicaid patients were less likely admitted to any PAC facility was than 
the commercially insured (OR: 0.94; 95% CI: 0.92 – 0.97; p < 0.001; AUC = 0.803). Overall, 
black patients and patients who were admitted to the ICU were significantly more likely to be 
discharged to an inpatient PAC facility regardless of insurance status. 
In the hierarchical regression analysis (Table 5), the results were significantly different 
when accounting for hospital random effects. Medicaid patients were less likely to be admitted to 
an inpatient PAC facility than commercially insured individuals (OR: 0.87; 95% CI: 0.84 – 0.91; 
p < 0.001). On the other hand, Medicaid patients were significantly more likely to be admitted to 
a higher intensive inpatient PAC facility than individuals with commercial insurance (OR: 1.60; 
95% CI: 1.51 – 1.70; p < 0.001). Individuals with Medicaid and commercial insurance were 
equally as likely to be admitted to any PAC facility (OR: 1.03; 95% CI: 1.00 – 1.07; p = 0.06). 
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2.5 DISCUSSION 
This study sought to determine whether Medicaid patients were as likely as commercially insured 
patients to receive similar levels of care during recovery after an acute hospitalization. Specifically, 
we wanted to provider potential estimates for what is expected for PAC utilization as a result of 
the Medicaid expansion. We concluded that the hierarchical regression models, which accounted 
for hospital random effects, were more credible than the multivariable logistic models since access 
to an inpatient PAC facility was highly variable among providers. The analysis of the primary 
outcome confirmed the hypothesis that Medicaid recipients were less likely to be sent to an 
inpatient PAC facility in the random hospital effects model. This result confirms and extends the 
findings of a joint replacement study that Medicaid patients are more likely to receive less intensive 
PAC than commercial and Medicare patients with similar severity of illness (Freburger et al., 
2011). On the other hand, the hierarchical model indicated that Medicaid patients were 
significantly more likely to receive more expensive and high intensive PAC. Furthermore, we 
observed that Medicaid expansion is likely to impact PAC utilization since the discharge pattern 
for Medicaid patients are significantly different than commercially insured patients. This finding 
has cost implications that states must consider since the major driver of healthcare spending and 
variation stems from PAC utilization (Medicare Payment Advisory Commission, 2011). How 
individual states will react to the Medicaid expansion remains to be seen. However, if there is a 
significant increase in PAC utilization in the upcoming years, then it could pave way for cost 
control measures that may impact hospital revenue and patient quality of care.  
We performed a sensitivity analysis to see the effect of insurance type on all PAC settings. 
Interestingly, for all PAC settings, including the low intensive home health care, Medicaid and 
commercially insured patients were equally as less likely to be discharged to any PAC facility. 
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This may suggest that Medicaid is compelled to use home health care over more intensive PAC 
setting such as SNFs due to its significantly lower cost.  However, this may also indicate that 
commercial insurers underutilize home health care. In either case, these results show that there is 
an insurance-based difference in PAC utilization, and it could draw attention towards standardizing 
PAC planning. Policymakers could label this as a cost control measure or a quality improvement 
program that would overuse and underuse of PAC. 
The differences in PAC utilization patterns between insurance types were substantially 
distinct. Although Medicaid patients were sicker than commercially insured patients in the cohort, 
they had a significantly lower proportion sent to inpatient PAC facilities. In contrast, Medicaid 
patients were significantly more likely to be admitted to a high intensive inpatient PAC facility. 
While discharge to an inpatient PAC facility does not necessarily mean better care, the discrepancy 
is still noteworthy. There are several possible reasons for this disparity. First, Medicaid may lack 
a uniform assessment to determine what level of care is medically necessary for each patient to 
recover after a hospitalization. Commercial insurers may have better algorithms in their plans to 
determine the appropriate level of care. The Pennsylvania Long Term Care Commission has 
recommended an adoption of a uniform assessment to determine levels of care which would 
streamline the process for hospitals and patients (Pennsylvania Long Term Care Commission, 
2014). However, this may be difficult for rural patients since access to more intensive forms of 
PAC care such as IRFs and LTCHs is greater in urban areas. In the end, this insurance-based 
difference tells us that we need to “right-size” PAC utilization by optimizing the decision-making 
process. 
Second, determinants for post-acute care under Pennsylvania Medicaid is managed through 
a waiver system with eligibility requirements including prior authorization from a physician. These 
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extra levels of bureaucracy create an inefficient system that could delay or prevent Medicaid 
patients from receiving appropriate levels of care. Although over 80% of Medicaid recipients in 
Pennsylvania are under managed care, long term care services are not covered under capitation 
payments (Centers for Medicare and Medicaid Services, 2014). A solution to this problem would 
be to shift long term care responsibilities to managed care for a more coordinated system. Managed 
care would be able to use their own assessment tools to determine appropriate levels of care for 
each patient. Still, it is unknown whether this would improve outcomes or encourage placement to 
a high intensive PAC facility without extra reimbursement incentives.  
Lastly, Pennsylvania Medicaid generally does not pay for care at an LTACH, which are 
the most expensive PAC setting. LTACHs provide highly intensive rehabilitation for critically ill 
patients. While commercially insured patients were less sick than Medicaid patients, a higher 
proportion were transferred to an LTACH (7.0% vs. 1.7%). Few states such as Washington do pay 
for LTACHs in their Medicaid programs, but it is not clear whether this is beneficial to the 
Medicaid population. Some Pennsylvania Medicaid managed care organizations allow exceptions 
for patients to be admitted to an LTACH. Nonetheless, Medicaid patients may benefit from more 
intensive PAC setting if deemed medically necessary.  
There were several limitations in this study. First, the study population was limited to 
inpatient discharge records in Pennsylvania. Although the dataset used gives a rare insight on 
comparing individuals insured commercially to Medicaid recipients, the population may not be 
representative of patients in other states. In addition, Medicaid rules vary greatly across states 
which reduces the generalizability of the results. Second, as with all administrative datasets, coding 
errors are not uncommon, which may have some effect on the accuracy of the models. Although 
the PHC4 dataset did contain the MediQual probability of death which is determined using clinical 
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and laboratory data, the variable was not used in the logistic models due to a high rate of 
missingness. As a result, the dataset lacks clinical data that may have significantly improve the 
models. Third, although we excluded individuals over the age of 65 to eliminate most dual-
eligibles, it did not exclude individuals who were poor and disabled and qualified for both 
Medicare and Medicaid. This may have affected our results since Medicare usually pays first for 
PAC claims. Fourth, we were not able to adjust for socioeconomic status such as income. While 
Medicaid status may give some indication of socioeconomic status, adjusting for income accounts 
for individuals that may be in the coverage gap or borderline qualifies for Medicaid or subsidies 
for the insurance marketplace. Lastly, the dataset limited our ability to follow patients through 
their episode of care, which could have provided better insight on the outcome of each PAC 
location and the accuracy of the discharge disposition codes. 
2.6 CONCLUSION 
Hospitalized Medicaid beneficiaries were as likely as similar patients with commercial insurance 
to be admitted to a PAC facility, but less likely to be admitted to an inpatient PAC facility. 
Nevertheless, the data suggests that Medicaid expansion may lead to an increase in PAC use due 
to the demand of services from new Medicaid enrollees, and that PAC use will be a major burden 
on states after the expansion. At the same time, Medicaid beneficiaries tend to be admitted to more 
intensive forms of PAC due to increased access in urban areas. To the degree that appropriate PAC 
can produce health and financial benefits, the data highlights opportunities for states to standardize 
their approach to PAC. This study has opened up avenues for further study on whether Medicaid 
recipients would have better outcomes as a result of receiving comparable levels of care as 
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individuals with other insurance types. Given the fact that Medicaid has reimbursement rates 
considerably lower than Medicare and private insurance, improving patient care for the low-
income community, especially after a hospital stay, will be a difficult challenge. 
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3.0  COMPARING INPATIENT POST-ACUTE CARE UTILIZATION PATTERNS 
BETWEEN FEE-FOR-SERVICE AND MANAGED CARE IN PENNSYLVANIA 
MEDICAID 
3.1 ABSTRACT 
Introduction 
In the past decade, there has been a rise in managed care organizations (MCO) directing health 
services utilization and cost for state Medicaid programs. With many states implementing or 
considering the recent Medicaid expansion, cost concerns have steered state policymakers towards 
MCOs to deliver healthcare to the majority of their respective Medicaid recipients. According to 
a Medicare Payment Advisory Commission report, post-acute care (PAC) utilization is a major 
driver of healthcare spending in the United States. As a result, it is important to determine if the 
shift towards MCOs and away from the old fee-for-service (FFS) delivery system will improve 
care coordination through the optimization of PAC utilization. In prior work we demonstrated: (a) 
that Medicaid beneficiaries use PAC at a rate similar to the commercially insured, yet also use less 
intense forms of PAC; and (b) that these differences may explain some of the differences in post-
acute mortality and readmission rates between Medicaid beneficiaries and the commercial insured. 
Here, we explore whether some of these differences may be moderated by MCOs. These results 
can be used to inform policymakers on whether to contract MCOs for future Medicaid expansions. 
 
 
 
20 
Objective 
The purpose of this study is to determine whether Medicaid managed care utilizes inpatient PAC 
differently than its FFS counterpart. 
 
Methods 
We performed a retrospective cohort study using Pennsylvania Medicaid claims data from 2007 
to 2011. Eligible patients were between the ages of 18 – 64 and diagnosed in the top 20 diagnosis 
related group that were discharged to an inpatient PAC. Multivariable logistic regression models 
were used to estimate the association between Medicaid delivery type and probability of discharge 
to an inpatient PAC. 
 
Results 
115,107 Medicaid unique claims were in the final analytic cohort, and 2,399 (2.1%) of these claims 
ended in a discharge to an inpatient PAC facility. FFS Medicaid patients had a significantly greater 
hospital length of stay (15.0 vs. 10.2) and admitted to the ICU more often (48.5% vs. 29.8%) than 
patients with managed care. Conditional on discharge to an inpatient PAC, Medicaid managed 
care patients were significantly more likely to be discharged to an IRF (59.5% vs. 34.9%) while 
the reverse holds true for SNF where FFS patients predominated (54.5% vs. 38.0%). In the 
multivariate analysis, Medicaid patients under managed care were more likely to be admitted to 
an inpatient PAC facility (SNF, IRF, LTACH) than FFS Medicaid patients (OR: 3.19; 95% CI: 
2.87 – 3.54; p < 0.001). Medicaid managed care patients were considerably more likely to be 
admitted to a high intensive inpatient PAC facility (IRF, LTACH) than FFS Medicaid patients 
(OR: 5.48; 95% CI: 4.73 – 6.34; p < 0.001).  
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Conclusions 
Medicaid managed care beneficiaries were more likely to be admitted to an inpatient PAC than 
their FFS counterparts. The impact of managed care in Pennsylvania appeared to be positive for 
Medicaid beneficiaries because of the shorter length of stay and admittance to more intensive 
rehabilitation settings under MCOs. Assuming MCOs are utilizing their capitated payments from 
the state efficiently, this study suggests opportunities for states to contract MCOs to manage their 
Medicaid programs with the expansion underway. 
3.2 INTRODUCTION 
As of March 2016, 32 states including D.C. have expanded Medicaid with some non-expansion 
states proposing alternative expansion plans for state legislature and federal approval (National 
Academy for State Health Policy).  The impact of the Medicaid expansion is significant in part 
that individuals who were uninsured previously and now insured by Medicaid are more likely to 
utilize healthcare services such as post-acute care (PAC) than when they were uninsured. Many 
states are concerned that an increase in healthcare utilization means a rise in healthcare costs thus 
more Medicaid spending. However, the Kaiser Family Foundation looked at the effects of the 
Medicaid expansion on state budgets and found that states have so far incurred only limited 
additional costs related to the considerable increase in enrollment and experienced savings in their 
Medicaid programs (Dorn, Francis, Rudowitz, & Snyder, 2015). To further control cost and 
utilization, states have used managed care organizations (MCO) to manage healthcare for 
Medicaid recipients. This includes improvements in care coordination, increased access through 
provider networks, and competition among MCOs that may lead to quality improvements and 
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lower costs. As a result, the proportion of Medicaid managed care beneficiaries have significantly 
increased from 58% in 2002 (Medicare, Services, Health, & Services, 2013) to 72% in 2013 
(Medicare, Services, Health, & Services, 2015). With Medicaid enrollment rising at a substantial 
rate due to the expansion, it is important to understand how managed care affects Medicaid 
recipients in terms of where they receive treatment to fully recover from acute illness and the 
quality of care compared to the rest of the population.  
Many previously uninsured Americans are now insured and have easier access to 
healthcare services as a result of the Affordable Care Act, which relaxed Medicaid income 
requirements, removed categorical eligibility requirements, and streamlined enrollment to reduce 
barriers in obtaining insurance. However, there is concern as to whether Medicaid recipients are 
receiving comparable quality of care as individuals insured through other means such as private 
insurance. One study demonstrated that managed care plans that served predominately Medicaid 
recipients had lower scores on most quality of care indicators than plans with commercially insured 
individuals only (Landon et al., 2007). In addition, the same study determined that plans which 
serve both Medicaid and commercial enrollees had no significant differences in quality of care 
scores over plans with just Medicaid beneficiaries (Landon et al., 2007). These lower quality scores 
among the Medicaid population could be attributed to smaller reimbursement rates in Medicaid 
fee-for-service (FFS) and managed care where states typically pay a fixed per member per month 
rate to an MCO. In 2012, Medicaid paid on average nationwide 66% of the amount Medicare 
reimburses for the same services and only six states have comparable or higher reimbursement 
rates for Medicaid than Medicare (Zuckerman, 2012). These lower rates may limit participation of 
primary care practices and PAC facilities in Medicaid provider networks which would affect 
access to care for low-income communities. In addition, studies have suggested that regions with 
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higher Medicaid fee rates is associated with higher physician acceptance rates for new Medicaid 
patients (Decker, 2007, 2012) and longer physician visit durations which could lead to higher 
quality of care (Decker, 2007). Nevertheless, other studies have shown that higher Medicaid fees 
alone do not necessarily increase access and quality of care significantly (Cunningham & 
O’Malley, 2009; Shen & Zuckerman, 2005). The ACA did mandate increases in Medicaid fees to 
Medicare levels to encourage provider participation in the expansion; however, the rate increase 
expired in 2014 and only 15 states continued to participate (Kaiser Family Foundation, 2012; 
Smith et al., 2014). The effects of the ACA mandated fee increase on access and quality of care 
have not yet been assessed. In any case, there are gaps in access and quality that needs to be 
addressed in the Medicaid population. 
Many states, especially those that have expanded Medicaid or plan to expand, have moved 
many of their Medicaid recipients from the traditional FFS delivery system to managed care plans 
in order to reduce expenditures. Despite having their own prior authorization and clinical 
guidelines to manage Medicaid patients, states believe that MCOs have the better tools and 
innovative system to administer care more efficiently and effectively. For instance, reports from 
the Medicare Payment Advisory Commission found that there is significant variation in spending 
on PAC, which includes skilled nursing facilities (SNF), inpatient rehabilitation facilities (IRF), 
and long-term acute care hospitals (LTACH) (Medicare Payment Advisory Commission, 2011).  
Although no reports point to significant variation in PAC Medicaid spending, MCOs are expected 
to focus on PAC utilization in Medicaid to control costs. However, this could lead to underuse of 
more intensive PAC settings such as IRFs to achieve cost savings. One study reported that 
Medicaid patients that underwent joint replacements were significantly less likely to receive care 
from more intensive and expensive PAC settings than individuals with commercial insurance or 
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Medicare with similar severity of illness (Freburger et al., 2011). Similarly in stroke survivors, 
Medicaid beneficiaries were nearly 75% less likely to receive care in an IRF than the less intensive 
and expensive SNF compared with commercially insured patients (L. Skolarus et al., 2012). Our 
previous work also showed that patients with commercial insurance were significantly more likely 
to receive care in a high intensive inpatient PAC facility such as an IRF and LTACH. Nevertheless, 
it is unknown if there is a difference in PAC use between Medicaid FFS and managed care (Figure 
3). Pennsylvania was one of the early adopters of Medicaid managed care, and the significant shift 
towards MCOs in Pennsylvania Medicaid over FFS in the past decade opens up the discussion on 
whether this would have a significant effect on the course of treatment through a patient’s episode 
of care. The general assumption is that sicker patients such as individuals admitted to the intensive 
care unit or mechanically ventilated are likely to be discharged to higher intensive PAC facilities 
which have the ability to provide the required rehabilitation and care necessary for recovery. If 
MCOs are not able to provide more efficient and effective care than Medicaid under FFS, then we 
can argue that the current shift to MCOs may not necessarily be beneficial for Medicaid patients. 
Nevertheless, states believe that MCOs have the ability to be more efficient and effective in 
coordinating care than the FFS system. 
The objective of this study is to determine whether Medicaid managed care utilizes 
inpatient PAC differently than Medicaid FFS. This study would inform policymakers on what is 
expected for PAC utilization in Medicaid FFS versus managed care. Whether this information can 
be used to show how efficiently managed care uses state Medicaid dollars or how this would 
impact patient quality of care depends on these differences. Furthermore, these results can impact 
policy decisions to contract MCOs to manage patients in the future. We hypothesize that there is 
a difference in PAC utilization between Medicaid FFS and managed care based on the fact that 
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both delivery types have very distinct methods to coordinate care. In this study, we will be focusing 
on Pennsylvania’s Medicaid program which has recently expanded Medicaid and a significant 
proportion of Medicaid patients in managed care plans. 
3.3 STUDY DATA AND METHODS 
3.3.1 Study Design and Population 
This was a retrospective cohort study using Pennsylvania Medicaid claims data from 2007 to 2011 
provided by the Pennsylvania Department of Human Services. The Medicaid claims record used 
in this study comprised the inpatient, enrollment, and provider files. These files contain 
information on demographics, diagnoses, revenue codes, Medicaid enrollment eligibility and 
dates, and provider type and specialty.  
The study population consists of Pennsylvania patients aged 18 – 64 who were enrolled in 
a HealthChoices managed care plan or placed in the traditional FFS delivery system from 2007 to 
2011. Medicaid recipients 65 and over were excluded due to their eligibility for Medicare and thus 
these individuals would be dually-eligible. Consequently, the Medicare cost-sharing rules for 
dually-eligibles would bias the results. The population was limited to the top 20 diagnosis related 
groups (DRG) that were discharged to an inpatient PAC facility. This would reduce confounding 
and create a more homogeneous population for robust comparison.  
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3.3.2 Study Variables 
We obtained patient demographics which includes age, gender, and race from the inpatient 
Medicaid claim records. Comorbidities were determined using an algorithm developed by 
Elixhauser, which uses ICD-9-CM codes in the inpatient claims (Agency for Health Care Research 
and Quality; Elixhauser et al., 1998). Intensive care unit (ICU) admission was determined using 
revenue codes (revenue code 200 – 202, 207 – 213, 219) provided by the inpatient Medicaid claim 
records (Quan et al., 2004). Mechanical ventilation was identified using ICD-9-CM procedure 
codes (Quan et al., 2004). Medicaid eligibility, which includes Supplemental Security Income 
(SSI), General Assistance (GA), and Temporary Assistance for Needy Families (TANF), was 
obtained from the enrollment files. 
The primary outcome variable was whether the hospitalization ended with a discharge to 
an inpatient PAC facility. The provider file was used to identify inpatient PAC facilities, which 
were defined as a SNF, IRF, or LTACH. Subsequently, we observed transfers within one day of 
discharge from an inpatient hospital to an inpatient PAC facility in the claims. This approach 
allows for a more accurate determination of discharge destinations instead of relying on discharge 
status codes, which has been shown to be only moderately accurate (Kahn & Iwashyna, 2010). 
The primary exposure was the Medicaid delivery type defined as enrolling in FFS or managed 
care. This information was obtained from the enrollment file which contains the delivery type and 
its associated enrollment dates. To determine the delivery type, the discharge date in the inpatient 
claims were matched up with the corresponding enrollment dates to confirm whether the patient 
was enrolled in a managed care plan or FFS at the time. For patients that were enrolled in Medicaid 
during the hospital stay, we used the same procedure to determine delivery type since the 
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proportion of managed care and FFS for these previously uninsured individuals reflected 
Pennsylvania rates. 
3.3.3 Analysis 
We examined patient and clinical characteristics of each Medicaid cohort using summary statistics. 
Differences between the comparison groups were tested using t-tests and chi-square tests for 
continuous and categorical variables, respectively. To determine the relationship between 
discharge to an inpatient PAC facility and Medicaid delivery type, a multivariate logistic 
regression model was used. The model was risk-adjusted for all demographic variables, 
mechanical ventilation, ICU admission, hospital length of stay, Elixhauser comorbidities, and 
PHC4 region (Figure 4). We adjusted for geographic region since some areas of Pennsylvania had 
limited access to Medicaid managed care during the study period. The proportion of FFS Medicaid 
recipients was higher in rural regions than more urban areas (Table 6). Medicaid eligibility was 
also adjusted in our model since patients eligible for Medicaid through the TANF program were 
more likely to enroll in managed care (Table 8). Lastly, we included diagnosis related groups in 
the models due to the significant differences in diagnoses (Table 8).  All continuous variables such 
as age were converted to quadratic splines to provide a better model fit (Howe et al., 2011). In 
addition, we included only hospital survivors not discharged to a hospice in our regression models 
to account for death as a competing risk in discharge to an inpatient PAC facility. To account for 
differences in provider characteristics and clustering, we also performed a hierarchical linear 
model with random hospital effects. While we included geographic region as a fixed effect, the 
random effects model considers the hospital-to-hospital variability of patient treatment depending 
on access to an inpatient PAC facility. Data management and statistical analyses were performed 
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using SAS 9.4 (SAS Institute Inc.) and Stata SE 14.0 (StataCorp. 2015. Stata Statistical Software: 
Release 14. College Station). A p-value of 0.05 or below was classified as statistically significant. 
3.4 STUDY RESULTS 
There were 2,715,537 inpatient claims in Pennsylvania Medicaid during the study period. After 
applying the exclusion criteria, 115,107 unique claims were in the final analytic cohort with 44,392 
(38.6%) and 70,715 (61.4%) classified as FFS and managed care, respectively (Figure 5). Of those 
in the final cohort, 2,399 (2.1%) of these claims ended in a discharge to an inpatient PAC facility. 
For hospitalizations ending with discharge to an inpatient PAC facility, the proportion of Medicaid 
patients with FFS rose steadily from 2007 to 2011 while inpatient PAC utilization patterns 
remained relatively stable during this period (Table 7). However, parsing out these patterns by 
Medicaid delivery type reveals a different picture (Table 8). For FFS recipients, the number of 
discharges to SNFs increased significantly (58.2% to 75.2%) while discharges to IRFs decreased 
(35.9% to 18.6%) during the study period. In contrast, Medicaid beneficiaries served by managed 
care experienced the reverse patterns with discharges to IRFs notably increasing (50.8% to 65.4%) 
while discharges to SNFs decreasing (43.2% to 30.0%) throughout the study. These trends 
demonstrate a distinction in discharge patterns between the delivery types with these differences 
widening as time moved forward. 
The patient characteristics of the two Medicaid cohorts displayed some interesting 
differences and similarities (Table 9). Medicaid FFS beneficiaries had a significantly higher 
proportion of white beneficiaries than the managed care group. This is likely due to the fact that 
some rural areas in Pennsylvania did not have any HealthChoices plans available. While both 
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Medicaid cohorts have similar severity of illness in terms of comorbidity count and the presence 
of severe comorbid conditions, FFS recipients were considerably more likely to be admitted to the 
ICU (48.5% vs. 29.8%) and mechanically ventilated (10.6% vs. 6.5%) than patients with managed 
care. Furthermore, hospital length of stay for FFS Medicaid patients were substantially longer than 
their managed care counterparts (15.0 vs. 10.2 days). Yet, Medicaid managed care patients were 
significantly more likely to be discharged to an IRF (59.5% vs. 34.9%) while the reverse holds 
true for SNF where FFS patients predominated (54.5% vs. 38.0%). 
The multivariate logistic regression analysis examined two outcomes of varying intensities 
(Table 10). The analysis suggested that Medicaid patients with managed care were more likely to 
be discharged to an inpatient PAC than FFS recipients (OR: 3.29; 95% CI: 2.97 – 3.64; p < 0.001; 
AUC = 0.881). We also performed a sensitivity analysis and tested the likelihood of discharge to 
a high intensive inpatient PAC facility which includes only IRFs and LTACHs. For this outcome, 
Medicaid patients with managed care were considerably more likely to be discharged to a high 
intensive inpatient PAC than FFS recipients (OR: 5.24; 95% CI: 4.54 – 6.06; p < 0.001; AUC = 
0.910). Interestingly, mechanically ventilated patients were as likely to be discharged to an 
inpatient PAC facility than patients who were not ventilated (OR: 1.07; 95% CI: 0.84 – 1.36; p 
=0.601) even when the cohort was limited to hospital survivors not discharged to a hospice. The 
odds were smaller for discharges to a high intensive inpatient PAC facility (OR: 1.07; 95% CI: 
0.78 – 1.47; p =0.666). In the hierarchical regression analysis (Table 11), the effects of Medicaid 
delivery type on discharge to an inpatient PAC were similar when accounting for hospital random 
effects. Medicaid patients with managed care were more likely to be discharged to an inpatient 
PAC than FFS recipients (OR: 3.19; 95% CI: 2.87 – 3.54; p < 0.001). In addition, Medicaid patients 
with managed care were considerably more likely to be discharged to a high intensive inpatient 
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PAC than FFS recipients (OR: 5.48; 95% CI: 4.73 – 6.34; p < 0.001). There were no notable 
differences in the effects of patient demographics and frailty on the primary outcome. 
Lastly, we stratified our cohort by urbanicity to determine whether this relationship 
persisted throughout regions of Pennsylvania (Table 12). In urban regions, which included the 
Pittsburgh and Philadelphia metropolitan area, the odds were stronger for Medicaid managed care 
patients discharged to either an inpatient PAC (OR: 4.20; 95% CI: 3.68 – 4.80; p < 0.001; ROC = 
0.885) and a high intensive inpatient PAC facility than FFS beneficiaries (OR: 5.42; 95% CI: 4.50 
– 6.51; p < 0.001; ROC = 0.905). However, in rural areas, which consisted of all other regions, the 
relationship was weaker for either discharge to an inpatient PAC facility (OR: 2.16; 95% CI: 1.85 
– 2.53; p < 0.001; ROC = 0.880) and a high intensive inpatient PAC facility (OR: 4.64; 95% CI: 
3.73 – 5.78; p < 0.001; ROC = 0.905). When accounting for hospital random effects (Table 13), 
the odds for discharge to an inpatient PAC were similar for both urban (OR: 4.08; 95% CI: 3.56 – 
4.68; p < 0.001) and rural (OR: 2.14; 95% CI: 1.82 – 2.51; p < 0.001). Similarly, the odds for 
discharge to a high intensive inpatient PAC remained steady for urban (OR: 5.38; 95% CI: 4.46 – 
6.48; p < 0.001) and rural (OR: 4.66; 95% CI: 3.73 – 5.81; p < 0.001) areas. 
3.5 DISCUSSION 
In Pennsylvania Medicaid, patients in managed care plans receive care in higher intensive and 
more expensive PAC facilities than recipients in the traditional FFS system. Moreover, the PAC 
utilization patterns in Medicaid managed care plans reflected that of commercial insurance from 
our previous study. The increase in IRF utilization throughout the study period especially during 
its sudden rise in 2010 suggests a shift in payment policy. In fact, the Pennsylvania Department of 
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Public Welfare established supplemental payments to IRFs participating in the Medicaid program 
starting in July 2010 (Alexander, 2012; Dichter, 2010). This policy change likely affected the 
utilization of IRFs in two ways. First, the propensity of IRFs accepting Medicaid patients increased 
with the incentive of an additional payment. Second, the increased reimbursements opened up an 
opportunity to discharge patients in need of a higher intensive PAC setting to an IRF instead of 
either prolonging the hospital stay or discharging to a SNF or home health setting which may not 
have been adequate enough for full rehabilitation. On the other hand, the incentives may encourage 
hospitals to discharge patients to a high intensive PAC setting earlier to avoid incurring additional 
cost due to prolonged hospital stays. This would result in possible overuse of high intensive PAC 
facilities. Ultimately, these results supported our hypothesis that traditional FFS had distinct PAC 
utilization patterns as managed care plans in Medicaid. 
While IRF utilization increased in managed care during the study period, we observed a 
significant decrease in the proportion of discharges to an IRF in Medicaid FFS. There are a few 
reasons why there is a large discrepancy in PAC utilization patterns between Medicaid managed 
care and FFS. The state Medicaid FFS system may have stricter prior authorization requirements 
for high intensive PAC settings due to costs. On the other hand, MCOs have the resources, 
established care coordination, and high negotiation clout to afford high intensive PAC settings 
when medically necessary. It is also likely that the state of Pennsylvania has paid MCOs at a high 
enough fixed per member per month rate to continue participating in the Medicaid program and 
allow for enough resources to utilize high intensive PAC facilities. Another possibility is that 
Medicaid FFS overuses SNFs due to its lower cost and more relaxed requirements. However, it 
can be argued that there are more available SNFs that accept Medicaid patients than IRFs and 
LTACHs. Incidentally, Pennsylvania Medicaid does not pay for LTACH stay because of its 
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extremely high costs; however, an administrative waiver request may be filled out by the provider 
if it is deemed medically necessary (Pennsylvania Department of Human Services, 2012). 
According to our results, the amount of discharges to an LTACH is rare compared to SNFs and 
IRFs in both delivery systems.  
The differences in patient characteristics between delivery system were considerably 
different especially during the hospital stay. One significant demographic difference is that the 
proportion of nonwhites were significantly less in Medicaid FFS than managed care. This is likely 
due to the minimal availability of HealthChoices managed care plans in rural areas during the 
study period. Consequently, Medicaid beneficiaries that live in rural areas may have limited access 
to acute care hospitals and other essential health services such as PAC facilities. This constrained 
supply may explain why Medicaid FFS beneficiaries have on average 4.8 days longer hospital 
length of stay and significantly more likely to be admitted to the ICU than patients in managed 
care plans. According to a study, nearly half of trauma patients with hospital length of stay of 10 
days or longer experienced discharge delays due to difficulty in PAC placement (Hwabejire et al., 
2013). Not only does the availability of high intensive PAC facilities affect inpatient care and 
utilization PAC patterns, but also the use of case managers to coordinate care for Medicaid 
patients. MCOs have more established networks and innovative care coordination than the state 
FFS system, which likely leads to fewer delays during transitions of care. 
An alternative to FFS and managed care, which was used primarily for rural areas, is the 
Primary Care Case Management (PCCM) program. PCCMs have been used in other states which 
acts as a hybrid between FFS and managed care. In this plan, the state pays a fixed rate to a primary 
care provider or case manager to coordinate care and health services are reimbursed under the FFS 
model. During the study period, Pennsylvania had a PCCM program called ACCESS Plus that was 
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available for Medicaid beneficiaries in rural counties who did not voluntarily participate in the 
HealthChoices managed care plan. According to our sensitivity analysis, the PCCM program did 
not seem to have as much effect on PAC utilization. We believe that availability of PAC facilities 
likely had a significant effect on PAC utilization patterns in rural areas than delivery type. In 2013, 
the ACCESS Plus program was phased out and mandatory enrollment in an MCO was required 
for all Medicaid beneficiaries with some exceptions. 
There were several limitations in this study. First, the study population was limited to 
Medicaid claims in Pennsylvania. While the population may not be representative of patients in 
other states, the dataset we analyzed contained 100% of Medicaid claims that were submitted in 
the state. Furthermore, state Medicaid policy varies widely among states and can change with time. 
The Pennsylvania Medicaid policy has changed significantly from our study period to the current 
times. However, many states still either do not have or have a limited proportion of Medicaid 
beneficiaries enrolled in managed care plans. Our study would inform policymakers in those states 
to consider contracting MCOs over maintaining the traditional FFS system. Second, administrative 
datasets contains some coding errors that may have some effect on the accuracy of our models. 
Nevertheless, our claims dataset gave us the ability to avoid relying on inaccurate discharge status 
codes (Kahn & Iwashyna, 2010). Third, we were not able to adjust for socioeconomic status such 
as income. While Medicaid status may give some indication of socioeconomic status, adjusting 
for income accounts for individuals that may be in the coverage gap or borderline qualifies for 
Medicaid or subsidies for the insurance marketplace. Lastly, even though we excluded 
beneficiaries over the age of 65 to restrict dual-eligibles, it did not exclude recipients who were 
poor and disabled. This may have affected some of our results since Medicare funds are initially 
exhausted before using Medicaid dollars for PAC claims.  
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3.6 CONCLUSION 
Medicaid managed care beneficiaries were more likely to be admitted to an inpatient PAC than 
recipients in the traditional FFS system. These PAC utilization patterns reflect that of commercial 
insurance from our previous study. The impact of managed care in Pennsylvania appeared to be 
positive for Medicaid beneficiaries because of the shorter length of stay and admittance to more 
intensive rehabilitation under MCOs. This may be due to better care coordination. While 
Pennsylvania currently mandates Medicaid recipients to enroll in a HealthChoices managed care 
plan with few exceptions, this study can inform other states that still have a vested Medicaid FFS 
system. Assuming MCOs are utilizing their capitated payments from the state efficiently, this study 
suggests opportunities for states to contract MCOs to manage their Medicaid programs with the 
expansion underway. Pennsylvania is one of 32 states to expand Medicaid, and they are doing so 
using their managed care system which should be a model for other states to replicate. This would 
ensure that new and current Medicaid recipients receive the highest quality of care possible through 
proper patient management and care coordination. 
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4.0  THE IMPACT OF POST-ACUTE CARE UTILIZATION IN MEDICAID AND 
COMMERCIAL INSURANCE ON PATIENT OUTCOMES 
4.1 ABSTRACT 
Introduction 
Medicaid expansion under the Affordable Care Act has insured numerous individuals who were 
without insurance which allowed them to take better advantage of essential health services such as 
post-acute care (PAC). Our previous research suggested that while Medicaid recipients were as 
likely as individuals with commercial insurance to be admitted to an inpatient PAC, they are 
considerably less likely to be discharged to a high intensive inpatient PAC such as an inpatient 
rehabilitation facility (IRF) and long-term acute care hospital (LTACH). Reduced utilization of 
certain inpatient PAC settings may translate into quality gaps between Medicaid and private 
insurance that could be reinforced under the Medicaid expansion. With the rapid expansion of 
Medicaid over the next several years, it is important to understand how PAC utilization patterns 
impact patient outcomes. 
 
Objective 
The purpose of this study is to determine the degree to which patient outcomes observed among 
Medicaid beneficiaries was mediated by variation in the intensity of PAC utilization. 
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Methods 
We performed a retrospective cohort study using Pennsylvania administrative inpatient discharge 
records. Eligible patients were between the ages of 18 – 64 and discharged to an inpatient PAC. 
We used a two-stage causal pathway modeling approach to determine the influence of PAC 
utilization on the relationship between insurance type and patient outcomes. Multivariable logistic 
regression models were fitted to estimate odds ratio for the relationship between insurance status 
and patient outcomes. These models adjust for only patient characteristics. Subsequently, another 
identical set of multivariate logistic models were fitted except with the addition of type of inpatient 
PAC facility. Marginal effects between these sets of models were calculated to estimate the 
mediating effect of PAC type on the relationship between insurance status and patient outcomes. 
 
Results 
40,603 records were in the final analytic cohort. The majority of patients that were discharged to 
an inpatient PAC facility were Medicaid beneficiaries (59.4 % vs. 40.6%; p < 0.001). However, 
commercially insured patients were more likely to be discharged to a high intensive inpatient PAC 
facility (IRF, LTACH) than individuals covered under Medicaid (54.7% vs. 26.2%; p < 0.001). In 
our models testing the association between insurance type and patient outcomes, controlling for 
PAC utilization rates increased the odds ratio of Medicaid beneficiaries being readmitted to a 
hospital (30-day marginal effect: 1.26; 90-day marginal effect: 1.14; 180-day marginal effect: 
1.11).  Conversely, controlling for PAC utilization rates had a significant, positive effect on 
mortality rates (30-day marginal effect: 0.78; 90-day marginal effect: 0.84; 180-day marginal 
effect: 0.86).  
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Conclusions 
PAC utilization patterns for hospitalized Medicaid beneficiaries impacted readmissions and 
mortality to a degree. These results should push states to standardize their approach to PAC and 
take necessary steps to improve patient management and care coordination among providers.   
4.2 INTRODUCTION 
The Medicaid program has been a healthcare safety net for millions of low-income and disabled 
Americans for over fifty years. Under the Medicaid expansion through the Affordable Care Act 
(ACA), enrollment in the program has increased since minimum income eligibility levels were 
raised for states that participated in the expansion. Recent numbers indicate that Medicaid 
enrollment has increased by 21% to more than 71 million Americans from the passage of the ACA, 
and this number is expected to rise as more states decide to participate (Kaiser Family Foundation, 
2015c) As a result, this safety net is becoming more vital under the current expansion. 
One of the main limitations of the Medicaid program is the historically low reimbursement 
rates compared to Medicare and commercial insurance. Only six states have Medicaid 
reimbursement rates comparable or higher than Medicare, and for the remaining states, Medicaid 
paid on average 66% of the amount Medicare reimburses for the same services (Zuckerman, 2012).  
These lower rates discourage many providers from accepting Medicaid patients which reduces 
access to primary care for individuals in low socioeconomic areas. Furthermore, this has created 
barriers to essential services such as post-acute care (PAC), which provides key benefits during 
recovery from acute illness. These barriers may eventually lead to gaps in quality of care between 
Medicaid beneficiaries and other insurance types. Nevertheless, studies have been mixed on 
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whether increasing Medicaid reimbursements would significantly narrow this access gap. It has 
been suggested that regions with higher Medicaid reimbursement rates were associated with higher 
physician acceptance rates for new Medicaid patients which means greater access to care and 
longer physician visit durations which may lead to better quality of care (Decker, 2007, 2012). On 
the other hand, other studies have shown that higher Medicaid fee rates alone do not significantly 
increase access and quality of care (Cunningham & O’Malley, 2009; Shen & Zuckerman, 2005). 
These inconsistent results suggest that there may be a deeper underlying issue beyond provider 
reimbursements.  
As previously shown in many studies, health care associated with Medicaid has been 
comparatively worse than with commercial insurance. All-cause hospital readmission rates were 
observed to be higher across all levels of severity of illness (Jiang & Wier, 2010), and the 
likelihood to be readmitted for heart failure and all-cause was 68% and 32% greater in Medicaid 
patients than the commercially insured, respectively (L. A. Allen, Tomic, Smith, Wilson, & 
Agodoa, 2012). These poorer patient outcomes could be attributed to anywhere from the lack of 
preventive care to the recovery and rehabilitation from a hospital stay. We know from a few studies 
that Medicaid beneficiaries had significantly lower scores on most quality of care measures such 
as screenings, immunizations, and chronic disease management than individuals with commercial 
insurance within the same plan or across all plans (Landon et al., 2007; Thompson, Ryan, Pinidiya, 
& Bost, 2003). However, the recent focus is now on PAC, and the concept that better coordination 
of care to ensure effective transitions between hospitals stays and PAC leads to fewer readmissions 
(Mechanic, 2014). 
Since a Medicare Payment Advisory Commission report found that there is significant 
variation in spending on PAC, considerable attention has been devoted to improving utilization of 
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these services such as skilled nursing facilities (SNF), long-term acute care hospitals (LTACH), 
and inpatient rehabilitation facilities (IRF) in order to lower healthcare costs (Medicare Payment 
Advisory Commission, 2011). This could mean developing better care coordination between the 
acute care provider and PAC facility. At the same time, it could mean limiting the use of PAC 
which could exclude patients that may need those services to recover from an illness. In previous 
work, we demonstrated that although Medicaid recipients tend to be discharged to PAC at 
comparable rates compared to patients with commercial insurance, Medicaid recipients have 
substantially decreased utilization to high intensity inpatient PAC such as IRFs and LTACHs (Le, 
2016). While lower utilization of these services does not necessarily equate to poorer quality of 
care, the significant differences in utilization between Medicaid beneficiaries and commercially 
insured individuals may explain at least part of the variations in patient outcomes.  
From our review of the literature, we observed the relationship between insurance type and 
patient outcomes. To build on these observations, we sought to determine the extent to which the 
increased mortality and readmissions observed among Medicaid beneficiaries was, in part, 
mediated by variation in the intensity of PAC utilization. While sicker patients such as individuals 
admitted to the intensive care unit or that developed high number of comorbidities likely translates 
to worse outcomes, we hypothesize that PAC utilization patterns have a significant effect on that 
relationship. Our previous work showed that there were discrepancies in PAC utilization between 
Medicaid and commercial insurance, especially in regards to high intensive PAC settings.13  The 
degree to which these PAC utilization patterns of either insurance type had an effect on patient 
outcomes is unknown (Figure 6). A large effect on the relationship between insurance type and 
patient outcomes could mean that PAC utilization needs to be “right-sized” in order to deliver 
more efficient and effective care. 
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The purpose of this study is to determine the degree to which patient outcomes observed 
among Medicaid beneficiaries was mediated by variation in the intensity of PAC utilization. We 
sought to identify Medicaid recipients and commercially insured patients who were discharged to 
an inpatient PAC facility. Subsequently, we wanted to determine the impact of these PAC 
utilization patterns in Medicaid and commercial insurance on readmission and mortality. We 
hypothesized based on previous literature that PAC utilization patterns for Medicaid recipients 
would have a negative effect on readmissions and mortality. This study is important since it will 
inform how the Medicaid expansion will influence patient outcomes, and consequently, potential 
added costs to the healthcare system. 
 
4.3 STUDY DATA AND METHODS 
4.3.1 Study Design and Population 
This was a retrospective cohort study using hospital discharge data from the Pennsylvania Health 
Care Cost Containment Council (PHC4) inpatient administrative dataset. This hospitalization level 
dataset contains detailed demographic, clinical, and utilization variables for all inpatient discharges 
statewide (Pennsylvania Health Care Cost Containment Council).  The study population consists 
of Pennsylvania patients aged 18 – 64 who were either enrolled in Medicaid (fee-for-service or 
managed care) or commercial insurance from January 1, 2008 to March 31, 2010. The reason for 
this age limitation was to exclude individuals that are dually-eligible and for whom Medicare cost-
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sharing rules may bias the results. The cohort was limited to patients that were discharged to an 
inpatient PAC facility. 
4.3.2 Study Variables 
We acquired patient demographics from the discharge records in the PHC4 dataset and we obtained 
information on comorbidities using an algorithm developed by Elixhauser, which uses ICD-9-CM 
codes on individual patient records (Agency for Health Care Research and Quality; Elixhauser et 
al., 1998). Intensive care unit (ICU) admission was determined using revenue codes (revenue code 
200 – 202, 207 – 213, 219) provided by the PHC4 revenue code dataset (Quan et al., 2004). 
Mechanical ventilation was identified using ICD-9-CM procedure codes (Quan et al., 2004). 
Inpatient PAC facility was defined as a SNF, LTACH, or IRF. Hospitalizations that ended with a 
discharge to an inpatient PAC facility was identified using the discharge codes in the PHC4 
inpatient records.  
In this study, readmissions and mortality were used to assess patient outcomes. 
Readmissions in both cohorts were defined as a readmission to any short-stay hospital within 30, 
90, and 180 days of being discharged from the index hospital stay. Only the initial readmission 
was counted to maintain independence of observations. Mortality was defined by the time of death 
(30, 90, and 180 days) occurring after admission to the index short-stay hospital. The observed 
number of days to death and date of death was included in the PHC4 inpatient record if the 
mortality had occurred. The primary predictor was insurance type which is either Medicaid 
coverage or commercial insurance.  
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4.3.3 Analysis 
We examined patient characteristics of the final analytic cohort using summary statistics. 
Differences between the two insurance types were tested using t-tests and chi-square tests for 
continuous and categorical variables, respectively. To determine the influence of PAC utilization 
on the relationship between insurance type and patient outcomes, we used a two-stage causal 
pathway modeling approach. First, we fit multivariable logistic regression models to estimate odds 
ratio for the relationship between insurance status and our two outcomes (readmission and 
mortality). These models adjust for only patient characteristics. Next, we fit a multivariate logistic 
models identical to the first but with the addition of type of inpatient PAC facility (SNF, IRF, 
LTACH). Subsequently, we calculated the marginal effect by dividing the pairwise odds ratios. 
This marginal effect can be interpreted as the mediating impact of PAC type on the relationship 
between insurance status and patient outcomes. The patient characteristics in the model consisted 
of demographic variables, mechanical ventilation, ICU admission, hospital length of stay, and 
Elixhauser comorbidities. All continuous variables such as age were converted to quadratic splines 
to provide a better model fit (Howe et al., 2011).  Data management and statistical analyses were 
performed using SAS 9.4 (SAS Institute Inc.) and Stata SE 14.0 (StataCorp. 2015. Stata Statistical 
Software: Release 14. College Station). A p-value of 0.05 or below was classified as significant. 
4.4 STUDY RESULTS 
Over the study period, there were 3,575,127 inpatient records in Pennsylvania. After applying the 
exclusion criteria, 40,603 records were in the final analytic cohort (Figure 7). Patient 
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characteristics in the cohort were stratified by insurance type (Table 11). Medicaid beneficiaries 
were more likely than commercially insured patients to be discharged to an inpatient PAC facility 
(59.4% vs. 40.6%). Medicaid recipients were younger and had a significantly higher proportion of 
nonwhite beneficiaries (43.3% versus 19.6%) than commercially insured individuals. Despite 
presenting with multiple and more severe comorbidities, Medicaid patients had a shorter length of 
stay, less likely to be admitted to the ICU, and equally as likely to be mechanically ventilated. At 
the same time, Medicaid patients were significantly less likely to be discharged to a high intensive 
inpatient PAC facility (IRF, LTACH) than individuals with commercial insurance (26.2% vs. 
54.7%; p < 0.001). Hospital readmission from PAC facility was higher in Medicaid patients for all 
three time points (30 day: 5.6% vs. 4.9%, p = 0.002; 90-day: 9.4% vs. 7.3%, p < 0.001; 180-day: 
10.8% vs. 8.1%, p < 0.001). In addition, unadjusted patient outcomes were higher in Medicaid 
patients (30 day: 2.8% vs. 1.6%, p < 0.001; 90-day: 9.1% vs. 5.3%, p < 0.001; 180-day: 14.4% vs. 
8.0%, p < 0.001). 
In the multivariate logistic regression analysis (Table 12), Medicaid patients were more 
likely to be readmitted to a hospital from the PAC facility and more likely to die than commercially 
insured patients after adjusting for only patient characteristics. These associations persisted in our 
second model for both readmissions and mortality after adjusting for inpatient PAC type. 
Nevertheless, the variation in the intensity of PAC utilization had distinct mediating effects on 
readmissions and mortality. In our models testing the association between insurance type and 
patient outcomes, controlling for PAC utilization rates increased the odds ratio of Medicaid 
beneficiaries being readmitted to a hospital (30-day marginal effect: 1.26; 90-day marginal effect: 
1.14; 180-day marginal effect: 1.11).  Conversely, controlling for PAC utilization rates had a 
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significant, positive effect on mortality rates (30-day marginal effect: 0.78; 90-day marginal effect: 
0.84; 180-day marginal effect: 0.86). 
4.5 DISCUSSION 
This study sought to determine the degree to which mortality and readmissions observed among 
Medicaid beneficiaries was mediated by variation in the intensity of PAC utilization. The degree 
to which this impacts patient outcomes is dependent on the PAC utilization rates for both insurance 
types. There were many reasons for the major discrepancies in PAC utilization between these two 
insurance types. First, Pennsylvania Medicaid does not pay for an LTACH stay likely due to its 
substantial price tag and unconvincing cost-effectiveness over other PAC settings such as an IRF 
or SNF. LTACHs provide highly intensive rehabilitation for critically ill patients which Medicaid 
patients may need to fully recover from acute illness. On the other hand, the issue could be that 
commercial insurers may be over-utilizing more intensive PAC facilities. In the end, it is difficult 
to determine the “correct” amount of PAC for these patients. Second, Medicaid has a waiver 
system that is expected to have stricter qualifications and cost limits for PAC determination than 
commercial insurance. The Pennsylvania Long Term Care Commission has acknowledged that 
there needs to be an adoption of a uniform assessment in Medicaid to determine appropriate levels 
of care that would streamline the process for providers and patients (Pennsylvania Long Term Care 
Commission, 2014). Third, low Medicaid reimbursement rates limits patients’ access to PAC 
facilities. This has been an ongoing issue since the inception of Medicaid. Fourth, we observed 
that the proportion of Medicaid patients with mental and behavioral illness is significantly higher 
than commercial insurance which may affect placement in a PAC facility. Lastly, Medicaid 
45 
patients are more likely to receive poorer coordination of care which may affect their discharge 
location. These patients are more likely to be in major teaching hospitals where there are more 
likely to receive penalties under the hospital readmissions reduction program (Joynt & Jha, 2013). 
As shown in this study, the Medicaid cohort were significantly more likely to be readmitted to a 
hospital. Furthermore, since a significant proportion of the Medicaid population has a mental or 
behavioral diagnoses, additional support and coordination among providers is necessary to prevent 
poor patient outcomes. 
Using the knowledge of these PAC utilization patterns, it is clearer to see how this effects 
the relationship between insurance type and readmissions and mortality. Our results supported the 
hypothesis that Medicaid recipients would experience worse readmissions than commercially 
insured patients. These results were consistent with previous literature (L. A. Allen et al., 2012; 
Jiang & Wier, 2010) that compared readmission rates between Medicaid beneficiaries and 
individuals with commercial insurance. Our results had a higher effect than previous studies. This 
could be due to several reasons. First, the commercial insurance cohort were all discharged to an 
inpatient PAC facility while only a fraction of the Medicaid cohort were treated similarly. In 
addition, the effects may have been greater since commercially insured patients were more likely 
to be discharged to a high intensive PAC facility such as an IRF and an LTACH. This is further 
supported by another study in patients with joint replacement procedures which found that 
Medicaid patients were more likely to receive less intensive PAC than commercially insured 
patients with similar severity of illness (Freburger et al., 2011). On the other hand, the stronger 
effects could be attributed to the significantly higher proportion of individuals with mental or 
behavioral disorders in the Medicaid population than in the commercial cohort. Trudnak, et al. 
examined readmission rates in the Medicaid population and found that individuals with mental or 
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behavioral disorders contribute to the highest proportion of readmissions with nearly 20% of all 
readmissions (Trudnak et al., 2014). This highlights the need to reevaluate care for individuals 
with mental or behavioral disorders or to revise qualifications for PAC determination.  
Conversely, adjusting for PAC utilization patterns decreased the odds of mortality in 
Medicaid patients which rejected the other part of our hypothesis. However, individuals with 
Medicaid coverage were still more likely to die than commercially insured patients. Other studies 
have observed higher likelihood of in-hospital mortality and complications in Medicaid patients 
undergoing major surgical operations (Kelz et al., 2004; LaPar et al., 2010). Combining these two 
findings, there are some reasons that Medicaid patients appear to still have a higher probability of 
mortality. First, Medicaid patients may be more likely to receive care from poor performing 
hospitals. This is supported by a study showing that Medicaid beneficiaries make up the largest 
proportion of patients in worst performing hospitals (Jha, Orav, & Epstein, 2011). Second, 
Medicaid patients may have experienced poor follow-up care or received unsatisfactory levels of 
PAC necessary for full rehabilitation. Consequently, this also has an effect on cost where 12.5% 
of Medicaid hospitalization payments in eighteen states were for hospital readmissions (Trudnak 
et al., 2014). While current PAC utilization patterns have increased the chance for survival, an 
increase in odds for readmission signals that the problem could be due to inefficient care. A 
solution to this problem is to change the way Medicaid reimburses for services. Currently, long 
term care services are not covered under capitation payments even under managed care. Medicaid 
should include PAC services under episode-based payments and then paid to managed care 
organizations to assess, care coordinate, and manage patients efficiently. This is similar to what 
has been done with the Hospital Readmissions Reduction Program carried out by the ACA. 
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There were several limitations in this study. First, the study population was limited to 
inpatient discharge records in Pennsylvania. The population may not be representative of patients 
in other states. In addition, Medicaid rules vary greatly across states which reduces the 
generalizability of the results. Coding errors are not uncommon in the administrative  
datasets which may have some effect on the accuracy of the models. Furthermore, the dataset lack 
clinical variables that may have significantly improve the models. Our dataset did contain the 
MediQual probability of death which is calculating using clinical and laboratory information; 
however, we did not risk-adjust for this variable in our models since the rate of missing was too 
high. Another limitation of our study was excluding individuals over the age of 65 to eliminate 
most dual-eligibles. This excludes a significant proportion of our population that were discharged 
to an inpatient PAC facilities. In addition, this exclusion did not remove individuals who were 
poor and disabled and qualified for both Medicaid and Medicare in which the latter pays first for 
PAC claims. We were not able to adjust for socioeconomic status such as income. While Medicaid 
status may give some indication of socioeconomic status, adjusting for income accounts for 
individuals that may be in the coverage gap or borderline qualifies for Medicaid or subsidies for 
the insurance marketplace. Lastly, administrative datasets limited our ability to follow patients 
through their episode of care, which would have provided more accurate discharge information as 
opposed to relying on discharge disposition codes. 
4.6 CONCLUSION 
The PAC utilization patterns for hospitalized Medicaid beneficiaries impacted patient outcomes to 
a degree. We do not know whether more PAC utilization for Medicaid patients would improve 
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outcomes. However, the poor readmission rates and significant discrepancies in PAC utilization 
patterns between these insurance types suggest that Medicaid underutilizes high intensive inpatient 
PAC in a way that may be deleterious for patient outcomes. Future research would investigate how 
payment reform such as implementing episode based payments would encourage better care 
coordination for Medicaid patients. These results should push states to standardize their approach 
to PAC and take necessary steps to improve patient management and care coordination among 
providers. With Pennsylvania participating in the Medicaid expansion, steps need to be taken to 
ensure that new and current beneficiaries receive high quality of care. 
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APPENDIX A – RELEVANT TABLES 
Table 1. Top 20 diagnosis related groups (DRG) discharged to an inpatient PAC facility (2008 – 2010 Q1) 
DRG 
(n=# of patients) 
PHC4 Cohort 
(n=40,603) 
Major joint replacement of lower extremity (470) 2960 (7.3) 
Tracheostomy with prolonged vent with major operation (003) 1555 (3.8) 
Psychoses (885) 1096 (2.7) 
Septicemia without prolonged vent (871) 949 (2.3) 
Intracranial hemorrhage or cerebral infarction with CC (065) 886 (2.2) 
Bilateral/multiple major joint proc of lower extremity (462) 880 (2.2) 
Tracheostomy with prolonged vent without major operation (004) 782 (1.9) 
Infectious and parasitic diseases with operation (853) 513 (1.3) 
Intracranial hemorrhage or cerebral infarction with MCC (064) 487 (1.2) 
Alcohol/drug abuse or dependence without rehab (897) 452 (1.1) 
Hip and femur procedure except major joint (481) 420 (1.0) 
Respiratory system diagnosis with 96+ hours ventilator support (207) 406 (1.0) 
Lower extremity and humerus procedure except hip, foot, femur without CC/MCC (494) 406 (1.0) 
Lower extremity and humerus procedure except hip, foot, femur with CC (493) 405 (1.0) 
Cellulitis without MCC (603) 390 (1.0) 
Rehabilitation with CC/MCC (945) 378 (0.9) 
Respiratory system diagnosis with less than 96 hours ventilator support (208) 373 (0.9) 
Limb reattachment, hip and femur procedure for multiple significant trauma (956) 372 (0.9) 
Intracranial hemorrhage or cerebral infarction without CC/MCC (066) 363 (0.9) 
Spinal fusion except cervical without MCC (460) 324 (0.8) 
Total (Top 20 DRGs) 14397 (35.5) 
All other DRGs 26206 (65.5) 
Values are frequency (percent)  
 
CC = Complication; MCC = Major complication 
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Table 2. Discharge location by insurance type for all patients (2008 – 2010 Q1) 
Characteristic 
(n=# of patients) 
Medicaid 
(n=61901) 
Commercial 
(n=72095) 
Home 40280 (65.1) 46127 (64.0) 
Other acute care hospital 1415 (2.3) 1355 (1.9) 
Dead 1567 (2.5) 977 (1.4) 
Post-acute care   
 SNF 4339 (7.0) 2951 (4.1) 
 IRF 2549 (4.1) 3870 (5.4) 
 LTACH 119 (0.2) 569 (0.8) 
 Home health 7030 (11.4) 13026 (18.1) 
Hospice 243 (0.4) 151 (0.2) 
Other 4359 (7.0) 3069 (4.3) 
Values are frequency (percent)  
 
SNF = Skilled Nursing Facility; IRF = Inpatient Rehabilitation Facility; LTACH = Long-Term Acute Care Hospital 
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Table 3. Patient characteristics – Discharged to an inpatient PAC facility (2008 – 2010 Q1) 
Characteristic 
(n=# of patients) 
Medicaid 
(n=7007) 
Commercial 
(n=7390) p-value 
Age 50.2 ± 10.8 52.0 ± 10.6 < 0.001 
Female 3586 (51.2) 3764 (50.9) 0.776 
Race    
     White 4022 (57.4) 5882 (79.6)  
     Black 2282 (32.6) 1024 (13.9) < 0.001 
     Other 703 (10.0) 484 (6.5)  
Admission source    
     Direct 2050 (31.6) 3491 (47.2)  
     Emergency Department 3834 (54.7) 3002 (40.6) < 0.001 
     Other Hospital 524 (7.5) 508 (6.9)  
     Other 599 (8.5) 389 (5.3)  
Comorbidity count    
     0 833 (11.9) 1598 (21.6)  
     1 1759 (25.1) 2190 (29.6) < 0.001 
     2 2042 (29.1) 1975 (26.7)  
     3+ 2373 (33.9) 1627 (22.0)  
Comorbidities    
     CHF 547 (7.8) 191 (2.6) < 0.001 
     COPD 1081 (15.4) 780 (10.6) < 0.001 
     Diabetes mellitus 1074 (15.3) 905 (12.2) < 0.001 
     Liver disease 278 (4.0) 146 (2.0) < 0.001 
     Metastatic cancer 99 (1.4) 72 (1.0) 0.015 
     Other cancer 79 (1.1) 47 (0.6) 0.001 
ICU Admission 2841 (40.5) 2178 (29.5) < 0.001 
Mechanical ventilation 2104 (30.0) 1419 (19.2) < 0.001 
MediQual predicted risk of death‡ 0.080 ± 0.142 0.054 ± 0.132 < 0.001 
Hospital length of stay 15.3 ± 20.9 11.2 ± 21.4 < 0.001 
ICU length of stay* 14.8 ± 16.3 15.3 ± 19.4 0.258 
Discharge location    
     SNF 4339 (61.9) 2951 (39.9)  
     IRF 2549 (36.4) 3870 (52.4) < 0.001 
     LTACH 119 (1.7) 569 (7.7)  
Values are mean ± standard deviation or frequency (percent)  
‡ - 19.2% missing 
* - Condition on ICU admission 
 
PAC = Post-Acute Care; CHF = Congestive Heart Failure; COPD = Chronic Obstructive Pulmonary Disease; ICU = 
Intensive Care Unit; SNF = Skilled Nursing Facility; IRF = Inpatient Rehabilitation Facility; LTACH = Long-Term 
Acute Care Hospital; MV = Mechanical Ventilation 
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Table 4. Adjusted odds ratio of discharge to a PAC facility without hospital random effects* 
Outcome Odds Ratio 95% Confidence Interval p-value 
Inpatient PAC**    
Medicaid (vs. Commercial) 1.083 [1.039, 1.129] < 0.001 
Female 1.074 [1.032, 1.117] < 0.001 
Race (vs. White)    
     Black  1.249 [1.184, 1.318] < 0.001 
     Other 0.949 [0.881, 1.023] 0.170 
ICU Admission 2.314 [1.803, 2.970] < 0.001 
Mechanical Ventilation 0.711 [0.649, 0.779] < 0.001 
High Intensive Inpatient PAC***    
Medicaid (vs. Commercial) 0.570 [0.539, 0.604] < 0.001 
Female 0.905 [0.859, 0.953] < 0.001 
Race (vs. White)    
     Black  1.181 [1.100, 1.269] < 0.001 
     Other 1.043 [0.949, 1.147] 0.384 
ICU Admission 2.706 [1.959, 3.738] < 0.001 
Mechanical Ventilation 0.602 [0.534, 0.680] < 0.001 
All PAC****    
Medicaid (vs. Commercial) 0.943 [0.915, 0.973] < 0.001 
Female 1.058 [1.028, 1.089] < 0.001 
Race (vs. White)    
     Black  1.051 [1.008, 1.095] 0.020 
     Other 0.934 [0.884, 0.986] 0.014 
ICU Admission 1.185 [0.957, 1.469] 0.120 
Mechanical Ventilation 0.654 [0.604, 0.709] < 0.001 
* Models adjusted for age, sex, race, admission source, Elixhauser comorbidities, comorbidity count, mechanical 
ventilation, ICU admission, hospital length of stay, ICU length of stay, and PHC4 region. 
** Inpatient PAC = SNF, IRF, LTACH vs. No PAC, HHA 
*** High Intensive Inpatient PAC = IRF, LTACH vs. No PAC, HHA, SNF 
**** All PAC = HHA, SNF, IRF, LTACH vs. No PAC 
 
PAC = Post-Acute Care; SNF = Skilled Nursing Facility; IRF = Inpatient Rehabilitation Facility; LTACH = Long 
Term Acute Care Hospital; HHA = Home Health Agency; ICU = Intensive Care Unit 
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Table 5. Adjusted odds ratio of discharge to a PAC facility with hospital random effects* 
Outcome Odds Ratio 95% Confidence Interval p-value 
Inpatient PAC**    
Medicaid (vs. Commercial) 0.873 [0.836, 0.912] < 0.001 
Female 1.104 [1.060, 1.149] < 0.001 
Race (vs. White)    
     Black  1.155 [1.092, 1.519] < 0.001 
     Other 0.980 [0.906, 1.059] 0.606 
ICU Admission 2.263 [1.753, 2.921] < 0.001 
Mechanical Ventilation 0.680 [0.619, 0.746] < 0.001 
High Intensive Inpatient PAC***    
Medicaid (vs. Commercial) 1.600 [1.510, 1.696] < 0.001 
Female 0.929 [0.881, 0.980] 0.007 
Race (vs. White)    
     Black  1.128 [1.048, 1.214] 0.001 
     Other 1.060 [0.962, 1.169] 0.239 
ICU Admission 2.646 [1.907, 3.673] < 0.001 
Mechanical Ventilation 0.589 [0.521, 0.667] < 0.001 
All PAC****    
Medicaid (vs. Commercial) 1.033 [0.999, 1.068] 0.056 
Female 1.088 [1.055, 1.121] < 0.001 
Race (vs. White)    
     Black  1.041 [0.996, 1.089] 0.077 
     Other 0.852 [0.803, 0.905] < 0.001 
ICU Admission 1.150 [0.922, 1.434] 0.214 
Mechanical Ventilation 0.613 [0.565, 0.665] < 0.001 
* Models accounted for hospital random effects and adjusted for age, sex, race, admission source, Elixhauser 
comorbidities, comorbidity count, mechanical ventilation, ICU admission, hospital length of stay, ICU length of 
stay, and PHC4 region. 
** Inpatient PAC = SNF, IRF, LTACH vs. No PAC, HHA 
*** High Intensive Inpatient PAC = IRF, LTACH vs. No PAC, HHA, SNF 
**** All PAC = HHA, SNF, IRF, LTACH vs. No PAC 
 
PAC = Post-Acute Care; SNF = Skilled Nursing Facility; IRF = Inpatient Rehabilitation Facility; LTACH = Long 
Term Acute Care Hospital; HHA = Home Health Agency; ICU = Intensive Care Unit 
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Table 6. Medicaid delivery type by PHC4 region 
PHC4 Region Fee-For-Service Managed Care 
Region 1 10187 (37.4) 17048 (62.6) 
Region 2 4292 (36.7) 7404 (63.3) 
Region 3 1677 (39.7) 2545 (60.3) 
Region 4 1419 (48.7) 1497 (51.3) 
Region 5 4089 (50.6) 3995 (49.4) 
Region 6 2925 (52.7) 2627 (47.3) 
Region 7 3634 (40.9) 5252 (59.1) 
Region 8 5430 (42.1) 7467 (57.9) 
Region 9 9099 (32.5) 18896 (67.5) 
Values are frequency (percent)  
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Table 7. Hospitalizations ending with discharge to an inpatient PAC facility by year (all DRGs) 
Year 2007 2008 2009 2010 2011 
Medicaid Delivery Type      
     Fee-For-Service 373 (26.0) 397 (29.5) 421 (26.4) 494 (37.0) 484 (33.3) 
     Managed Care 1063 (74.0) 949 (70.5) 1173 (73.6) 843 (63.1) 971 (66.7) 
Inpatient PAC      
     SNF 676 (47.1) 632 (47.0) 760 (47.7) 589 (44.1) 655 (45.0) 
     IRF 674 (46.9) 632 (47.0) 747 (46.9) 657 (49.1) 725 (49.8) 
     LTACH 86 (6.0) 82 (6.1) 87 (5.5) 91 (6.8) 75 (5.2) 
Values are frequency (percent)  
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Table 8. Hospitalizations ending with discharge to an inpatient PAC facility stratified by Medicaid delivery type (all 
DRGs) 
Year 2007 2008 2009 2010 2011 
Fee-For-Service      
   Inpatient PAC      
        SNF 217 (58.2) 230 (57.9) 275 (65.3) 350 (70.9) 364 (75.2) 
        IRF 134 (35.9) 137 (34.5) 108 (25.7) 114 (23.1) 90 (18.6) 
        LTACH 22 (5.9) 30 (7.6) 38 (9.0) 30 (6.1) 30 (6.2) 
Managed Care      
   Inpatient PAC      
        SNF 459 (43.2) 402 (42.4) 485 (41.4) 239 (28.3) 291 (30.0) 
        IRF 540 (50.8) 495 (52.2) 639 (54.5) 543 (64.4) 635 (65.4) 
        LTACH 64 (6.0) 52 (5.5) 49 (4.2) 61 (7.2) 45 (4.6) 
Values are frequency (percent)  
 
PAC = Post-Acute Care; SNF = Skilled Nursing Facility; IRF = Inpatient Rehabilitation Hospital; LTACH = Long-
Term Acute Care Hospital 
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Table 9. Patient characteristics – Discharged to an inpatient PAC facility (2007 – 2011) 
Table 9 Continued 
Characteristic 
(n=# of patients) 
Fee-For-Service 
(n=639) 
Managed Care 
(n=1760) p-value 
Age 50.0 ± 11.6 49.8 ± 10.9 0.672 
Female 291 (45.5) 1088 (61.8) < 0.001 
Race    
     White 480 (75.1) 920 (52.3)  
     Black 126 (19.7) 716 (40.7) < 0.001 
     Other 33 (5.2) 124 (7.0)  
Medicaid Eligibility    
     SSI 500 (78.2) 1377 (78.2)  
     GA 116(18.2) 238 (13.5) 0.305 
     TANF 23 (3.6) 145 (8.2)  
Comorbidity count    
     0 44 (6.9) 104 (5.9)  
     1 114 (17.8) 21 (18.2) 0.929 
     2 152 (23.8) 463 (26.3)  
     3+ 329 (51.5) 872 (49.5)  
Comorbidities    
     CHF 58 (9.1) 151 (8.6) 0.703 
     COPD 110 (17.2) 407 (23.1) 0.002 
     Diabetes mellitus 118 (18.5) 341 (19.4) 0.617 
     Liver disease 20 (3.1) 78 (4.4) 0.155 
     Metastatic cancer 8 (1.3) 15 (0.9) 0.375 
     Other cancer 10 (1.6) 17 (1.0) 0.219 
ICU Admission 310 (48.5) 525 (29.8) < 0.001 
Mechanical ventilation 68 (10.6) 114 (6.5) 0.001 
Hospital length of stay 15.0 ± 16.8 10.2 ± 13.7 < 0.001 
Diagnosis related groups    
     Major joint replacement of lower extremity 40 (6.3) 433 (24.6) < 0.001 
     Intracranial hemorrhage or cerebral infarction 112 (17.5) 291 (16.5) 0.565 
     Tracheostomy 78 (12.2) 139 (7.9) 0.001 
     Respiratory system diagnosis 32 (5.0) 74 (4.2) 0.398 
     Poisoning & toxic effects of drugs 32 (5.0) 70 (4.0) 0.434 
     Multiple sclerosis & cerebellar ataxia 7 (1.1) 67 (3.8) < 0.001 
     Hip and femur procedures 32 (5.0) 66 (3.8) 0.169 
     Lower extremity and humerus procedures 32 (5.0) 66 (3.8) 0.169 
     Bilateral/multiple major joint proc of lower extremity 6 (0.9) 62 (3.5) < 0.001 
     Craniotomy and endovascular intracranial proc 24 (3.8) 59 (3.4) 0.633 
     Septicemia 62 (9.7) 54 (3.1) < 0.001 
     Infectious and parasitic diseases with OR proc 42 (6.6) 48 (2.7) < 0.001 
     Renal failure 28 (4.4) 47 (2.7) 0.033 
     Extensive OR proc unrelated to principal diagnosis 15 (2.3) 47 (2.7) 0.660 
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Table 9 Continued 
Characteristic 
(n=# of patients) 
Fee-For-Service 
(n=639) 
Managed Care 
(n=1760) p-value 
     Amputation for circ sys disorders exclude upper limb 16 (2.5) 46 (2.6) 0.881 
     COPD 10 (1.6) 46 (2.6) 0.133 
     Cellulitis 24 (3.8) 31 (2.3) 0.057 
     Heart failure and shock 26 (4.1) 38(2.2) 0.010 
     Other OR proc for multiple significant trauma 17 (2.7) 34 (1.9) 0.274 
     Psychoses 15 (2.3) 32 (1.8) 0.409 
Discharge location    
     SNF 348 (54.5) 615 (34.9)  
     IRF 243 (38.0) 1048 (59.5) < 0.001 
     LTACH 48 (7.5) 97 (5.5)  
Values are mean ± standard deviation or frequency (percent)  
 
PAC = Post-Acute Care; CHF = Congestive Heart Failure; COPD = Chronic Obstructive Pulmonary Disease; ICU = 
Intensive Care Unit; SNF = Skilled Nursing Facility; IRF = Inpatient Rehabilitation Facility; LTACH = Long-Term 
Acute Care Hospital 
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Table 10. Adjusted odds ratio of discharge to an inpatient PAC facility without hospital random effects* 
Outcome Odds Ratio 95% Confidence Interval p-value 
Inpatient PAC**    
Managed Care (vs. Fee-For-Service) 3.289 [2.968, 3.644] < 0.001 
Female 1.113 [1.011, 1.224] 0.028 
Race (vs. White)    
     Black  1.023 [0.914, 1.144] 0.697 
     Other 0.657 [0.543, 0.794] < 0.001 
ICU Admission 1.502 [1.328, 1.699] < 0.001 
Mechanical Ventilation 1.067 [0.836, 1.362] 0.601 
High Intensive Inpatient PAC***    
Managed Care (vs. Fee-For-Service) 5.242 [4.539, 6.055] < 0.001 
Female 1.021 [0.903, 1.154] 0.744 
Race (vs. White)    
     Black  1.042 [0.901, 1.206] 0.576 
     Other 0.808 [0.636, 1.026] 0.080 
ICU Admission 1.649 [1.413, 1.923] < 0.001 
Mechanical Ventilation 1.072 [0.782, 1.468] 0.666 
* Models accounted for hospital random effects and adjusted for age, sex, race, admission source, Elixhauser 
comorbidities, comorbidity count, mechanical ventilation, ICU admission, hospital length of stay, ICU length of 
stay, Medicaid eligibility, diagnosis related groups, and PHC4 region 
** Inpatient PAC = SNF, IRF, LTACH 
*** High Intensive Inpatient PAC = IRF, LTACH 
 
PAC = Post-Acute Care; SNF = Skilled Nursing Facility; IRF = Inpatient Rehabilitation Facility; LTACH = Long-
Term Acute Care Hospital; ICU = Intensive Care Unit 
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Table 11. Adjusted odds ratio of discharge to an inpatient PAC facility with hospital random effects* 
Outcome Odds Ratio 95% Confidence Interval p-value 
Inpatient PAC**    
Managed Care (vs. Fee-For-Service) 3.189 [2.872, 3.540] < 0.001 
Female 1.104 [1.004, 1.216] 0.042 
Race (vs. White)    
     Black  0.985 [0.878, 1.104] 0.795 
     Other 0.680 [0.561, 0.825] < 0.001 
ICU Admission 1.574 [1.390, 1.784] < 0.001 
Mechanical Ventilation 1.077 [0.843, 1.376] 0.553 
High Intensive Inpatient PAC***    
Managed Care (vs. Fee-For-Service) 5.476 [4.727, 6.344] < 0.001 
Female 1.016 [0.899, 1.149] 0.604 
Race (vs. White)    
     Black  1.028 [0.888, 1.190] 0.209 
     Other 0.844 [0.666, 1.070] 0.467 
ICU Admission 1.779 [1.523, 2.080] < 0.001 
Mechanical Ventilation 1.096 [0.800, 1.502] 0.915 
* Models accounted for hospital random effects and adjusted for age, sex, race, admission source, Elixhauser 
comorbidities, comorbidity count, mechanical ventilation, ICU admission, hospital length of stay, ICU length of 
stay, Medicaid eligibility, diagnosis related groups, and PHC4 region 
** Inpatient PAC = SNF, IRF, LTACH 
*** High Intensive Inpatient PAC = IRF, LTACH 
 
PAC = Post-Acute Care; SNF = Skilled Nursing Facility; IRF = Inpatient Rehabilitation Facility; LTACH = Long-
Term Acute Care Hospital; ICU = Intensive Care Unit 
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Table 12. Adjusted odds ratio of discharge to an inpatient PAC facility stratified by urbanicity without hospital 
random effects 
 Urban* Rural** 
Outcome Odds Ratio 95% Confidence Interval Odds Ratio 
95% Confidence 
Interval 
Inpatient PAC***     
Managed Care (vs. Fee-For-Service) 4.201 [3.678, 4.799] 2.162 [1.847, 2.531] 
High Intensive Inpatient PAC****     
Managed Care (vs. Fee-For-Service) 5.416 [4.504, 6.512] 4.641 [3.728, 5.777] 
* PHC4 Region 1, 8, 9 
** PHC4 Region 2, 3, 4, 5, 6, 7 
*** Inpatient PAC = SNF, IRF, LTACH 
**** High Intensive Inpatient PAC = IRF, LTACH 
 
‡ Not significant @ 0.05 
 
PAC = Post-Acute Care; SNF = Skilled Nursing Facility; IRF = Inpatient Rehabilitation Facility; LTACH = Long-
Term Acute Care Hospital; ICU = Intensive Care Unit 
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Table 13. Adjusted odds ratio of discharge to an inpatient PAC facility stratified by urbanicity with hospital random 
effects 
 Urban* Rural** 
Outcome Odds Ratio 95% Confidence Interval Odds Ratio 
95% Confidence 
Interval 
Inpatient PAC***     
Managed Care (vs. Fee-For-Service) 4.079 [3.559, 4.675] 2.138 [1.824, 2.506] 
High Intensive Inpatient PAC****     
Managed Care (vs. Fee-For-Service) 5.380 [4.463, 6.484] 4.659 [3.733, 5.814] 
* PHC4 Region 1, 8, 9 
** PHC4 Region 2, 3, 4, 5, 6, 7 
*** Inpatient PAC = SNF, IRF, LTACH 
**** High Intensive Inpatient PAC = IRF, LTACH 
 
‡ Not significant @ 0.05 
 
PAC = Post-Acute Care; SNF = Skilled Nursing Facility; IRF = Inpatient Rehabilitation Facility; LTACH = Long-
Term Acute Care Hospital; ICU = Intensive Care Unit 
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Table 14. Patient characteristics – Admitted to an inpatient PAC facility 
Table 14 Continued 
Characteristic 
(n=# of patients) 
Commercial 
(n=16490) 
Medicaid 
(n=24113) p-value 
Age 52.1 ± 10.6 50.9 ± 10.7 < 0.001 
Female 7909 (48.0) 12076 (50.1) < 0.001 
Race    
     White 13256 (80.4) 13655 (56.6)  
     Black 2094 (12.7) 8400 (34.8) < 0.001 
     Other 1140 (6.9) 2058 (8.5)  
Admission source    
     Direct 6130 (37.2) 5345 (22.2)  
     Emergency Department 7928 (48.1) 14419 (59.8) < 0.001 
     Other Hospital 1229 (7.5) 1468 (6.1)  
     Other 1203 (7.3) 2881 (11.9)  
Comorbidity count    
     0 3398 (20.6) 2340 (9.7)  
     1 4650 (28.2) 5260 (21.8) < 0.001 
     2 4326 (26.2) 6963 (28.9)  
     3+ 4116 (25.0) 9550 (39.6)  
Comorbidities    
     CHF 573 (3.5) 1896 (7.9) < 0.001 
     COPD 1724 (10.5) 3828 (15.9) < 0.001 
     Diabetes mellitus 2103 (12.8) 3943 (16.4) < 0.001 
     Liver disease 365 (2.2) 1216 (5.0) < 0.001 
     Metastatic cancer 378 (2.3) 524 (2.2) 0.423 
     Other cancer 198 (1.2) 392 (1.6) < 0.001 
ICU Admission 5774 (35.0) 7755 (32.3) < 0.001 
Mechanical ventilation 2244 (13.6) 3375 (14.0) 0.266 
MediQual predicted risk of death‡ 0.048 ± 0.116 0.051 ± 0.108 0.056 
Hospital length of stay 10.9 ± 16.6 11.8 ± 15.3 < 0.001 
ICU length of stay* 9.9 ± 14.0 9.2 ± 12.6 0.003 
Discharge location    
     SNF 7468 (45.3) 17800 (73.8)  
     IRF 8104 (49.1) 6017 (25.0) < 0.001 
     LTACH 918 (5.6) 296 (1.2)  
Outcomes    
     Readmissions    
          30-Day 802 (4.9) 1339 (5.6) 0.002 
          90-Day 1196 (7.3) 2260 (9.4) < 0.001 
          180-Day 1339 (8.1) 2615 (10.8) < 0.001 
     Mortality    
          30-Day 269 (1.6) 678 (2.8) < 0.001 
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Table 14 Continued 
Characteristic 
(n=# of patients) 
Commercial 
(n=16490) 
Medicaid 
(n=24113) p-value 
          90-Day 882 (5.3) 2186 (9.1) < 0.001 
          180-Day 1325 (8.0) 3473 (14.4) < 0.001 
Values are mean ± standard deviation or frequency (percent)  
‡ - 18.8% missing 
* - Condition on ICU admission 
 
CHF = Congestive Heart Failure; COPD = Chronic Obstructive Pulmonary Disease; ICU = Intensive Care Unit; 
SNF = Skilled Nursing Facility; IRF = Inpatient Rehabilitation Facility; LTACH = Long-Term Acute Care Hospital 
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Table 15. Adjusted odds ratios (OR) of patient outcomes 
Outcome Model 1 OR* 95% Confidence Interval Model 2 OR** 
95% Confidence 
Interval 
Marginal 
Effect 
Readmission – Medicaid (vs. Commercial)    
     30-Day 1.101‡ [0.999, 1.214] 1.382 [1.249, 1.529] 1.255 
     90-Day 1.234 [1.140, 1.335] 1.405 [1.294, 1.526] 1.139 
     180-Day 1.278 [1.186, 1.377] 1.414 [1.308, 1.528] 1.106 
Mortality – Medicaid (vs. Commercial)    
     30-Day 1.751 [1.496, 2.048] 1.370 [1.164, 1.611] 0.782 
     90-Day 1.706 [1.558, 1.868] 1.429 [1.299, 1.572] 0.838 
     180-Day 1.847 [1.712, 1.993] 1.581 [1.459, 1.713] 0.856 
* OR adjusted for age, sex, race, admission source, Elixhauser comorbidities, comorbidity count, mechanical 
ventilation, ICU admission, hospital length of stay, and ICU length of stay 
** OR adjusted for patient characteristics and type of PAC facility (SNF, IRF, LTACH) 
 
‡ Not significant @ 0.05 
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APPENDIX B – RELEVANT FIGURES 
 
Figure 1. Overall conceptual model 
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Figure 2. Conceptual model (Paper 1) 
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Figure 3. Exclusion criteria and final cohort (Paper 1) 
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Figure 4. Conceptual model (Paper 2) 
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Figure 5. Exclusion criteria and final cohort (Paper 2) 
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Figure 6. PHC4 regions (Pennsylvania Health Care Cost Containment Council) 
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Figure 7. Conceptual model (Paper 3) 
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Figure 8. Exclusion criteria and final cohort (Paper 3) 
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